Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_002074.5(GNB1):c.239T>C (p.Ile80Thr)	GNB1	I80T	not provided|Mental retardation, autosomal dominant 42|Global developmental delay|Myelodysplastic syndrome|LEUKEMIA, CHRONIC LYMPHOCYTIC, SOMATIC|Neurodevelopmental disorder|Neurodevelopmental abnormality|Seizures|hypotonia|Neurodevelopmental Disability|Inborn genetic diseases|Dystonia|Upper limb hypertonia|Hypothyroidism|Growth delay|Infantile axial hypotonia|Cleft palate|Intellectual disability|Intellectual disability|Muscular hypotonia|Developmental regression|Seizures|EEG with generalized epileptiform discharges|Inability to walk|Growth delay|Expressive language delay|Strabismus|Failure to thrive|Global developmental delay|Nystagmus|Limb hypertonia|Multifocal epileptiform discharges	Pathogenic/Likely pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000208722	1	1737942	1	1806503	208722	205216	rs752746786	NC_000001.11:1806502:A:G
NM_004958.4(MTOR):c.5930C>T (p.Thr1977Ile)	MTOR	T1977I	not provided|CEBALID syndrome|Focal cortical dysplasia type II|MTOR-related megalencephaly and pigmentary mosaicism in skin	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000584432	1	11188164	1	11128107	584432	575484	rs587777893	NC_000001.11:11128106:G:A
NM_004958.4(MTOR):c.5395G>A (p.Glu1799Lys)	MTOR	E1799K	Focal cortical dysplasia type II|Inborn genetic diseases|Smith-Kingsmore syndrome|Rare genetic intellectual disability|CEBALID syndrome|not provided|Intellectual disability|Intellectual disability, severe	Pathogenic(Last reviewed: Aug 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000217823	1	11190804	1	11130747	217823	214480	rs863225264	NC_000001.11:11130746:C:T
NM_000478.6(ALPL):c.648+1G>A	ALPL		not provided|Hypophosphatasia|Hypophosphatasia, perinatal lethal|Infantile hypophosphatasia	Pathogenic(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013678	1	21890710	1	21564217	13678	28717	rs749544042	NC_000001.11:21564216:G:A
NM_002524.5(NRAS):c.182A>G (p.Gln61Arg)	NRAS	Q61R	Melanoma|Malignant neoplasm of body of uterus|Nasopharyngeal Neoplasms|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Adrenocortical carcinoma|Neoplasm of the large intestine|Glioblastoma|Chronic lymphocytic leukemia|Transitional cell carcinoma of the bladder|Epidermal nevus syndrome|Large congenital melanocytic nevus|Neurocutaneous melanocytosis|Epidermal nevus|Thyroid cancer, nonmedullary, 2|Neoplasm of brain|Lung adenocarcinoma|Multiple myeloma|Malignant melanoma of skin|Non-small cell lung cancer|Renal cell carcinoma, papillary, 1|not provided|Hepatocellular carcinoma|Acute myeloid leukemia	Pathogenic(Last reviewed: May 4, 2015)	criteria provided, multiple submitters, no conflicts	VCV000013900	1	115256529	1	114713908	13900	28939	rs11554290	NC_000001.11:114713907:T:C
NM_002524.5(NRAS):c.38G>A (p.Gly13Asp)	NRAS	G13D	Neoplasm of the large intestine|Myelodysplastic syndrome|not provided|Adenocarcinoma of stomach|Juvenile myelomonocytic leukemia|Multiple myeloma|RAS-associated autoimmune leukoproliferative disorder|Noonan syndrome 6|Acute myeloid leukemia|Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Melanoma|Medulloblastoma|Non-Hodgkin lymphoma|Acute megakaryoblastic leukemia in down syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013901	1	115258744	1	114716123	13901	28940	rs121434596	NC_000001.11:114716122:C:T
NM_002524.5(NRAS):c.35G>T (p.Gly12Val)	NRAS	G12V	Melanoma|Myelodysplastic syndrome|Neoplasm of the large intestine|Acute myeloid leukemia|Multiple myeloma|Rasopathy|Malignant melanoma of skin|not provided|Noonan syndrome|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040470	1	115258747	1	114716126	40470	48940	rs121913237	NC_000001.11:114716125:C:A
NM_002524.5(NRAS):c.34G>A (p.Gly12Ser)	NRAS	G12S	Neoplasm of the large intestine|Myelodysplastic syndrome|not provided|Rasopathy|Multiple myeloma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Acute myeloid leukemia|Malignant melanoma of skin|Non-small cell lung cancer|Melanoma|Juvenile myelomonocytic leukemia|Noonan syndrome	Pathogenic(Last reviewed: Nov 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177778	1	115258748	1	114716127	177778	172332	rs121913250	NC_000001.11:114716126:C:T
NM_002524.5(NRAS):c.34G>C (p.Gly12Arg)	NRAS	G12R	Chronic myelogenous leukemia, BCR-ABL1 positive|Myelodysplastic syndrome|Neoplasm of the large intestine|Increased nuchal translucency|Acute myeloid leukemia|Malignant melanoma of skin|Multiple myeloma|Non-small cell lung cancer|not provided|Melanoma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach	Pathogenic(Last reviewed: Jun 2, 2015)	criteria provided, multiple submitters, no conflicts	VCV000040469	1	115258748	1	114716127	40469	48939	rs121913250	NC_000001.11:114716126:C:G
NM_170707.4(LMNA):c.1580G>C (p.Arg527Pro)	LMNA	R527P, R446P, R415P	Familial partial lipodystrophy 2|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Charcot-Marie-Tooth disease, type 2|Primary dilated cardiomyopathy|not provided	Pathogenic(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000014481	1	156106995	1	156137204	14481	29520	rs57520892	NC_000001.11:156137203:G:C
NM_024529.4(CDC73):c.131+1G>A	CDC73		Parathyroid carcinoma|Hyperparathyroidism 1|Parathyroid adenoma, somatic|not provided	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003276	1	193091462	1	193122332	3276	18315	rs587776558	NC_000001.11:193122331:G:A
NM_022552.5(DNMT3A):c.2644C>T (p.Arg882Cys)	DNMT3A	R693C, R882C, R730C, R659C	Lung adenocarcinoma|Neurodevelopmental disorder|Inborn genetic diseases|Acute myeloid leukemia|not provided|Tatton-Brown-rahman syndrome|Myelodysplastic syndrome	Pathogenic(Last reviewed: Aug 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000375882	2	25457243	2	25234374	375882	362761	rs377577594	NC_000002.12:25234373:G:A
NM_004304.5(ALK):c.3824G>A (p.Arg1275Gln)	ALK	R1275Q, R207Q	Neuroblastoma|Breast neoplasm|not provided|Neuroblastoma 3|Neoplasm of brain	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000018083	2	29432664	2	29209798	18083	33122	rs113994087	NC_000002.12:29209797:C:T
NM_014946.4(SPAST):c.1245+1G>A	SPAST		not provided|Inborn genetic diseases|Spastic paraplegia 4, autosomal dominant	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000226113	2	32353549	2	32128480	226113	227916	rs875989878	NC_000002.12:32128479:G:A
NM_000251.2(MSH2):c.198C>A (p.Tyr66Ter)	MSH2	Y66*	Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000645593	2	47630528	2	47403389	645593	630084	rs730881784	NC_000002.12:47403388:C:A
NM_000251.2(MSH2):c.212-1G>A	MSH2		Lynch-like syndrome|not provided|Hereditary cancer-predisposing syndrome|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090892	2	47635539	2	47408400	90892	96367	rs267607914	NC_000002.12:47408399:G:A
NM_000251.2(MSH2):c.226C>T (p.Gln76Ter)	MSH2	Q76*, Q10*	Lynch-like syndrome|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090945	2	47635554	2	47408415	90945	96420	rs63750042	NC_000002.12:47408414:C:T
NM_000251.2(MSH2):c.366+1G>A	MSH2		Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000245947	2	47635695	2	47408556	245947	244372	rs267607924	NC_000002.12:47408555:G:A
NM_000251.2(MSH2):c.478C>T (p.Gln160Ter)	MSH2	Q160*, Q94*	Lynch-like syndrome|Hereditary nonpolyposis colon cancer|Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091103	2	47637344	2	47410205	91103	96578	rs63751426	NC_000002.12:47410204:C:T
NM_000251.3(MSH2):c.490G>A	MSH2	G164R, G98R	Lynch syndrome|Lynch-like syndrome|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colon cancer|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000091109	2	47637356	2	47410217	91109	96584	rs63750582	NC_000002.12:47410216:G:A
NM_000251.3(MSH2):c.942+3A>T	MSH2		Lynch-like syndrome|not provided|Lynch syndrome I|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Carcinoma of colon|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036580	2	47641560	2	47414421	36580	45242	rs193922376	NC_000002.12:47414420:A:T
NM_000251.3(MSH2):c.1013G>A	MSH2	G338E, G272E	Lynch syndrome|Lynch-like syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090504	2	47643505	2	47416366	90504	95979	rs587779065	NC_000002.12:47416365:G:A
NM_000251.3(MSH2):c.1034G>A	MSH2	W345*, W279*	Lynch syndrome|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090509	2	47643526	2	47416387	90509	95984	rs63751027	NC_000002.12:47416386:G:A
NM_000251.3(MSH2):c.1147C>T (p.Arg383Ter)	MSH2	R383*, R317*	not provided|Hereditary cancer-predisposing syndrome|Lynch-like syndrome|Lynch syndrome I|Muir-Torré syndrome|Turcot syndrome|Lynch syndrome I|Hereditary nonpolyposis colon cancer|Rhabdomyosarcoma (disease)|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090554	2	47656951	2	47429812	90554	96029	rs63749849	NC_000002.12:47429811:C:T
NM_000251.2(MSH2):c.1276+1G>A	MSH2		Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|Carcinoma of colon|Lynch syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090590	2	47657081	2	47429942	90590	96065	rs267607950	NC_000002.12:47429941:G:A
NM_000251.2(MSH2):c.1276+2T>C	MSH2		not provided|Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Lynch syndrome I	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000218032	2	47657082	2	47429943	218032	214582	rs267607953	NC_000002.12:47429942:T:C
NM_000251.3(MSH2):c.1277-2A>G	MSH2		Hereditary cancer-predisposing syndrome|Lynch syndrome|Lynch-like syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090605	2	47672685	2	47445546	90605	96080	rs267607949	NC_000002.12:47445545:A:G
NM_000251.2(MSH2):c.1511-1G>A	MSH2		Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000619529	2	47693796	2	47466657	619529	610972	rs267607964	NC_000002.12:47466656:G:A
NM_000251.3(MSH2):c.1662-1G>A	MSH2		Hereditary nonpolyposis colorectal neoplasms|Hereditary cancer-predisposing syndrome|Mismatch repair cancer syndrome 2|Lynch-like syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090727	2	47698103	2	47470964	90727	96202	rs267607970	NC_000002.12:47470963:G:A
NM_000251.2(MSH2):c.1738G>T (p.Glu580Ter)	MSH2	E580*, E514*	Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Lynch-like syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090763	2	47698180	2	47471041	90763	96238	rs63751411	NC_000002.12:47471040:G:T
NM_000251.2(MSH2):c.1759+1G>T	MSH2		Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000566832	2	47698202	2	47471063	566832	561641	rs587779108	NC_000002.12:47471062:G:T
NM_000251.3(MSH2):c.1764T>G	MSH2	Y588*, Y522*	Lynch syndrome|Lynch-like syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090780	2	47702168	2	47475029	90780	96255	rs63750844	NC_000002.12:47475028:T:G
NM_000251.2(MSH2):c.1777C>T (p.Gln593Ter)	MSH2	Q593*, Q527*	Lynch syndrome|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090783	2	47702181	2	47475042	90783	96258	rs63750200	NC_000002.12:47475041:C:T
NM_000251.2(MSH2):c.1861C>T (p.Arg621Ter)	MSH2	R621*, R555*	Lynch syndrome I|Turcot syndrome|Muir-Torré syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch syndrome I|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090804	2	47702265	2	47475126	90804	96279	rs63750508	NC_000002.12:47475125:C:T
NM_000251.3(MSH2):c.2038C>T (p.Arg680Ter)	MSH2	R680*, R614*	Lynch-like syndrome|Lynch syndrome I|Hereditary nonpolyposis colorectal neoplasms|Malignant tumor of ascending colon|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036572	2	47703538	2	47476399	36572	45234	rs63749932	NC_000002.12:47476398:C:T
NM_000251.3(MSH2):c.2131C>T (p.Arg711Ter)	MSH2	R711*, R645*	not provided|Hereditary nonpolyposis colorectal neoplasms|not specified|Lynch-like syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome I|Muir-Torré syndrome|Turcot syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090903	2	47703631	2	47476492	90903	96378	rs63750636	NC_000002.12:47476491:C:T
NM_000179.3(MSH6):c.1483C>T	MSH6	R495*, R193*, R365*	Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|Hereditary cancer-predisposing syndrome|Carcinoma of colon|Lynch syndrome|not provided	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089197	2	48026605	2	47799466	89197	94671	rs587779212	NC_000002.12:47799465:C:T
NM_000179.3(MSH6):c.3202C>T	MSH6	R1068*, R766*, R938*	Endometrial carcinoma|Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|not provided|Hereditary nonpolyposis colorectal cancer type 5|Turcot syndrome|Endometrial carcinoma|Lynch syndrome I|Hereditary nonpolyposis colorectal cancer type 5|Carcinoma of colon|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089352	2	48030588	2	47803449	89352	94826	rs63749843	NC_000002.12:47803448:C:T
NM_000179.3(MSH6):c.3477C>A	MSH6	Y1159*, Y857*, Y1029*	Hereditary cancer-predisposing syndrome|not provided|Carcinoma of colon|Lynch syndrome|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic/Likely pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000092577	2	48032087	2	47804948	92577	98485	rs398123231	NC_000002.12:47804947:C:A
NM_000179.3(MSH6):c.3964G>T	MSH6	E1322*, E1192*, E1020*	Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch-like syndrome	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000433932	2	48033753	2	47806614	433932	427193	rs1553333707	NC_000002.12:47806613:G:T
NM_001111067.4(ACVR1):c.983G>A (p.Gly328Glu)	ACVR1	G328E	Brainstem glioma|Progressive myositis ossificans|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Oct 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000029595	2	158622516	2	157766004	29595	38549	rs387906589	NC_000002.12:157766003:C:T
NM_001040142.2(SCN2A):c.4976C>T (p.Ala1659Val)	SCN2A	A1659V	Seizures, benign familial infantile, 3|not provided|Seizures|Early infantile epileptic encephalopathy 11|Seizures, benign familial infantile, 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000410984	2	166245292	2	165388782	410984	391639	rs1060503101	NC_000002.12:165388781:C:T
NM_001282386.1(IDH1):c.395G>A (p.Arg132His)	IDH1	R132H	Glioma susceptibility 1|not provided|Neoplasm of the large intestine|Metaphyseal enchondromatosis with d-2-hydroxyglutaric aciduria|Adenocarcinoma of prostate|Adenoid cystic carcinoma|Astrocytoma|Myelodysplastic syndrome|Glioblastoma multiforme, somatic|Breast neoplasm|Neoplasm of brain|Oligodendroglioma|Hepatocellular carcinoma|Acute myeloid leukemia|Malignant melanoma of skin|Glioblastoma|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Multiple myeloma|Medulloblastoma	Pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156444	2	209113112	2	208248388	156444	166215	rs121913500	NC_000002.12:208248387:C:T
NM_001282386.1(IDH1):c.394C>T (p.Arg132Cys)	IDH1	R132C	Neoplasm of the large intestine|Brainstem glioma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Astrocytoma|Neoplasm of brain|not provided|Adenoid cystic carcinoma|Adenocarcinoma of prostate|Malignant melanoma of skin|Acute myeloid leukemia|Glioblastoma|Multiple myeloma|Breast neoplasm|Lung adenocarcinoma|Medulloblastoma|Myelodysplastic syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000375891	2	209113113	2	208248389	375891	362770	rs121913499	NC_000002.12:208248388:G:A
NM_001354689.3(RAF1):c.1897C>G (p.Leu633Val)	RAF1	L613V, L633V, L499V, L580V, L552V, L532V	LEOPARD syndrome 2|Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome with multiple lentigines|not provided|Noonan syndrome|Familial hypertrophic cardiomyopathy 1|Rasopathy|Noonan syndrome 5	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013960	3	12626123	3	12584624	13960	28999	rs80338797	NC_000003.12:12584623:G:C
NM_001354689.3(RAF1):c.1532C>T (p.Thr511Ile)	RAF1	T491I, T511I, T430I, T410I, T458I, T377I	Rasopathy|Cardiovascular phenotype|not provided|Noonan syndrome|Noonan syndrome with multiple lentigines	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000021342	3	12627244	3	12585745	21342	34194	rs80338799	NC_000003.12:12585744:G:A
NM_001354689.3(RAF1):c.788T>C (p.Val263Ala)	RAF1	V263A, V182A, V149A, V230A	not provided|Rasopathy|Noonan syndrome	Pathogenic(Last reviewed: Jun 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040608	3	12645681	3	12604182	40608	49078	rs397516830	NC_000003.12:12604181:A:G
NM_001354689.3(RAF1):c.782C>T (p.Pro261Leu)	RAF1	P261L, P180L, P228L, P147L	Noonan syndrome 5|Rasopathy|not provided|Noonan syndrome|Cardiomyopathy, dilated, 1NN	Pathogenic/Likely pathogenic(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000120246	3	12645687	3	12604188	120246	125840	rs397516828	NC_000003.12:12604187:G:A
NM_001354689.3(RAF1):c.781C>G (p.Pro261Ala)	RAF1	P261A, P180A, P147A, P228A	Noonan syndrome 5|LEOPARD syndrome 2|Cardiomyopathy, dilated, 1NN|Rasopathy|not provided|Primary familial hypertrophic cardiomyopathy|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000040605	3	12645688	3	12604189	40605	49075	rs121434594	NC_000003.12:12604188:G:C
NM_001354689.3(RAF1):c.781C>T (p.Pro261Ser)	RAF1	P261S, P180S, P147S, P228S	not provided|Inborn genetic diseases|Rasopathy|Cardiovascular phenotype|Noonan syndrome|Noonan syndrome 5|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013958	3	12645688	3	12604189	13958	28997	rs121434594	NC_000003.12:12604188:G:A
NM_001354689.3(RAF1):c.770C>T (p.Ser257Leu)	RAF1	S257L, S224L, S143L, S176L	Adenocarcinoma of stomach|Neoplasm of the large intestine|Rasopathy|none provided|Inborn genetic diseases|Cardiomyopathy, dilated, 1NN|Noonan syndrome 5|LEOPARD syndrome 2|Noonan syndrome with multiple lentigines|Noonan syndrome|Noonan syndrome|Lung adenocarcinoma|Malignant melanoma of skin|Noonan syndrome 5|LEOPARD syndrome 2|not provided|Noonan syndrome 1|Noonan syndrome with multiple lentigines	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013957	3	12645699	3	12604200	13957	28996	rs80338796	NC_000003.12:12604199:G:A
NM_024334.3(TMEM43):c.1073C>T (p.Ser358Leu)	TMEM43	S358L	Cardiovascular phenotype|Cardiomyopathy|Familial isolated arrhythmogenic right ventricular dysplasia|Primary dilated cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy, type 5|not provided|Hypertrophic cardiomyopathy|Arrhythmogenic right ventricular cardiomyopathy	Pathogenic(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000734	3	14183165	3	14141665	734	15773	rs63750743	NC_000003.12:14141664:C:T
NM_003242.6(TGFBR2):c.1583G>A (p.Arg528His)	TGFBR2	R528H, R553H	Loeys-Dietz syndrome|not provided|Familial thoracic aortic aneurysm and aortic dissection|Hereditary nonpolyposis colorectal cancer type 6|Loeys-Dietz syndrome 2	Pathogenic(Last reviewed: Feb 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000012511	3	30732970	3	30691478	12511	27550	rs104893815	NC_000003.12:30691477:G:A
NM_000404.4(GLB1):c.176G>A (p.Arg59His)	GLB1	R59H, R107H, R29H	Mucopolysaccharidosis, MPS-IV-B|GM1-gangliosidosis, type I, with cardiac involvement|Infantile GM1 gangliosidosis|not provided|GM1 gangliosidosis|Infantile GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 3|GM1 gangliosidosis type 2|GM1 gangliosidosis|Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis type 2|GM1 gangliosidosis type 3	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000945	3	33114105	3	33072613	945	15984	rs72555392	NC_000003.12:33072612:C:T
NM_000249.4(MLH1):c.199G>A (p.Gly67Arg)	MLH1	G67R	Lynch syndrome II|Hereditary nonpolyposis colorectal neoplasms|Carcinoma of colon|Lynch-like syndrome|Hereditary nonpolyposis colon cancer|Hereditary cancer-predisposing syndrome|Lynch syndrome I|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089992	3	37038192	3	36996701	89992	95466	rs63750206	NC_000003.12:36996700:G:A
NM_000249.4(MLH1):c.298C>T	MLH1	R100*	not provided|Hereditary cancer-predisposing syndrome|Hereditary nonpolyposis colorectal neoplasms|Lynch syndrome II|Lynch-like syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036550	3	37042536	3	37001045	36550	45212	rs63751221	NC_000003.12:37001044:C:T
NM_000249.4(MLH1):c.350C>T (p.Thr117Met)	MLH1	T117M, T84M, T19M	Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|not provided|Lynch syndrome|Endometrial carcinoma|Lynch syndrome II|Hereditary cancer-predisposing syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017094	3	37045935	3	37004444	17094	32133	rs63750781	NC_000003.12:37004443:C:T
NM_000249.3(MLH1):c.545+3A>G	MLH1		not provided|Lynch syndrome II|Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090260	3	37050399	3	37008908	90260	95734	rs267607760	NC_000003.12:37008907:A:G
NM_000249.3(MLH1):c.676C>T (p.Arg226Ter)	MLH1	R226*, R128*, R193*	Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|Lynch syndrome|Lynch syndrome II|Hereditary cancer-predisposing syndrome|not provided|Turcot syndrome|Lynch syndrome I	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000017087	3	37053589	3	37012098	17087	32126	rs63751615	NC_000003.12:37012097:C:T
NM_000249.4(MLH1):c.677G>A (p.Arg226Gln)	MLH1	R226Q, R128Q, R193Q	Lynch syndrome II|Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|Lynch syndrome I|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090318	3	37053590	3	37012099	90318	95792	rs63751711	NC_000003.12:37012098:G:A
NM_000249.3(MLH1):c.790+1G>A	MLH1		Hereditary nonpolyposis colorectal neoplasms|Lynch-like syndrome|Lynch syndrome I|Hereditary cancer-predisposing syndrome|not provided|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090356	3	37056036	3	37014545	90356	95830	rs267607789	NC_000003.12:37014544:G:A
NM_000249.3(MLH1):c.793C>A (p.Arg265Ser)	MLH1	R265S, R167S, R232S, R24S	Carcinoma of colon|Lynch-like syndrome|Lynch syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Oct 18, 2018)	reviewed by expert panel	VCV000090380	3	37058999	3	37017508	90380	95854	rs63751194	NC_000003.12:37017507:C:A
NM_000249.4(MLH1):c.1381A>T (p.Lys461Ter)	MLH1	K461*, K220*, K363*, K120*, K103*, K428*	Hereditary cancer-predisposing syndrome|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms|not provided|Turcot syndrome|Muir-Torré syndrome|Lynch syndrome II|Lynch syndrome II|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000036540	3	37067470	3	37025979	36540	45202	rs63750540	NC_000003.12:37025978:A:T
NM_000249.4(MLH1):c.1459C>T	MLH1	R487*, R246*, R389*, R129*, R146*, R454*	Lynch syndrome II|Hereditary nonpolyposis colorectal neoplasms|not provided|Lynch-like syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome II|Muir-Torré syndrome|Turcot syndrome|Lynch syndrome I|Carcinoma of colon|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089744	3	37070324	3	37028833	89744	95218	rs63749795	NC_000003.12:37028832:C:T
NM_000249.3(MLH1):c.1667G>A (p.Ser556Asn)	MLH1	S556N, S198N, S523N, S458N, S215N, S315N	Hereditary cancer-predisposing syndrome|Lynch syndrome I|not provided|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic/Likely pathogenic(Last reviewed: Feb 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000449776	3	37081785	3	37040294	449776	443423	rs63751596	NC_000003.12:37040293:G:A
NM_000249.3(MLH1):c.1731+1G>A	MLH1		Lynch-like syndrome|Hereditary cancer-predisposing syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089848	3	37083823	3	37042332	89848	95322	rs267607853	NC_000003.12:37042331:G:A
NM_000249.3(MLH1):c.1731+2T>C	MLH1		Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000455399	3	37083824	3	37042333	455399	452139	rs267607856	NC_000003.12:37042332:T:C
NM_000249.3(MLH1):c.1791G>A (p.Trp597Ter)	MLH1	W597*, W356*, W499*, W239*, W256*, W564*	Hereditary cancer-predisposing syndrome|Lynch-like syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000480903	3	37089069	3	37047578	480903	473466	rs1416171624	NC_000003.12:37047577:G:A
NM_000249.3(MLH1):c.1989+5G>C	MLH1		Lynch syndrome|Hereditary nonpolyposis colorectal neoplasms	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000089977	3	37090105	3	37048614	89977	95451	rs267607878	NC_000003.12:37048613:G:C
NM_000249.3(MLH1):c.2011G>T (p.Glu671Ter)	MLH1	E671*, E616*, E640*, E573*, E313*, E330*, E430*, E638*	Lynch-like syndrome|Lynch syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000089999	3	37090416	3	37048925	89999	95473	rs63750663	NC_000003.12:37048924:G:T
NM_000249.3(MLH1):c.2098C>T (p.Gln700Ter)	MLH1	Q700*, Q459*, Q602*, Q667*, Q359*, Q669*, Q342*, Q645*	not provided|Lynch-like syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000483543	3	37090503	3	37049012	483543	473514	rs1553664702	NC_000003.12:37049011:C:T
NM_000249.3(MLH1):c.2136G>A (p.Trp712Ter)	MLH1	W712*, W354*, W471*, W681*, W614*, W643*, W657*, W679*, W371*	Lynch syndrome|Lynch-like syndrome	Pathogenic(Last reviewed: Sep 5, 2013)	reviewed by expert panel	VCV000090066	3	37092009	3	37050518	90066	95540	rs63750499	NC_000003.12:37050517:G:A
NM_001664.4(RHOA):c.139G>A (p.Glu47Lys)	RHOA	E47K	not provided|Hemihypertrophy|neuro-ectodermal phenotype|Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies|ECTODERMAL DYSPLASIA WITH FACIAL DYSMORPHISM AND ACRAL, OCULAR, AND BRAIN ANOMALIES, SOMATIC MOSAIC	Pathogenic(Last reviewed: May 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000695069	3	49412884	3	49375451	695069	683186	rs1575653629	NC_000003.12:49375450:C:T
NM_001145661.2(GATA2):c.1192C>T (p.Arg398Trp)	GATA2	R398W, R384W	GATA2 deficiency with susceptibility to MDS/AML|Lymphedema, primary, with myelodysplasia|Leukemia, acute myeloid, susceptibility to|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency|not provided|Acute myeloid leukemia|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency|Lymphedema, primary, with myelodysplasia	Pathogenic(Last reviewed: Jul 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029709	3	128200113	3	128481270	29709	38664	rs387906629	NC_000003.12:128481269:G:A
NM_001145661.2(GATA2):c.1061C>T (p.Thr354Met)	GATA2	T354M, T340M	Lymphedema, primary, with myelodysplasia|GATA2 deficiency with susceptibility to MDS/AML|not provided|Acute myeloid leukemia|Lymphedema, primary, with myelodysplasia|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency|Leukemia, acute myeloid, susceptibility to|Myelodysplastic syndrome|Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency	Pathogenic(Last reviewed: Jul 6, 2021)	criteria provided, multiple submitters, no conflicts	VCV000029711	3	128200744	3	128481901	29711	38666	rs387906631	NC_000003.12:128481900:G:A
NM_006218.4(PIK3CA):c.263G>A (p.Arg88Gln)	PIK3CA	R88Q	Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Cowden syndrome|not provided|Glioblastoma|Transitional cell carcinoma of the bladder|Brainstem glioma|Neoplasm of the large intestine|Neoplasm of ovary|Breast neoplasm|Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Oct 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376049	3	178916876	3	179199088	376049	362928	rs121913287	NC_000003.12:179199087:G:A
NM_006218.4(PIK3CA):c.1030G>A (p.Val344Met)	PIK3CA	V344M	Neoplasm of uterine cervix|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Malignant melanoma of skin|Cowden syndrome|Breast neoplasm|Non-Hodgkin lymphoma|Squamous cell carcinoma of the head and neck|Diaphragmatic eventration|Megalencephaly|Intestinal duplication|Abnormality of the hairline|Hypertelorism|Glioblastoma|not provided|Cowden syndrome 5	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000376498	3	178921548	3	179203760	376498	363377	rs1057519942	NC_000003.12:179203759:G:A
NM_006218.4(PIK3CA):c.1093G>A (p.Glu365Lys)	PIK3CA	E365K	Cowden syndrome|Neoplasm of ovary|not provided|Megalencephaly-capillary malformation-polymicrogyria syndrome	Pathogenic(Last reviewed: Aug 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419222	3	178922324	3	179204536	419222	406150	rs1064793732	NC_000003.12:179204535:G:A
NM_006218.4(PIK3CA):c.1633G>A (p.Glu545Lys)	PIK3CA	E545K	Carcinoma of colon|Carcinoma of esophagus|Seborrheic keratosis|OVARIAN CANCER, EPITHELIAL, SOMATIC|Malignant melanoma of skin|Lung adenocarcinoma|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Breast adenocarcinoma|Gallbladder cancer|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Nasopharyngeal Neoplasms|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Hepatocellular carcinoma|Neoplasm of stomach|Brainstem glioma|Transitional cell carcinoma of the bladder|PIK3CA related overgrowth spectrum|Abnormality of cardiovascular system morphology|Non-small cell lung cancer|Neoplasm of ovary|Sarcoma|Pancreatic adenocarcinoma|Breast neoplasm|Small cell lung carcinoma|Neoplasm of brain|Uterine Carcinosarcoma|Carcinoma of gallbladder|Papillary renal cell carcinoma, sporadic|Neoplasm of uterine cervix|Squamous cell carcinoma of the head and neck|not provided|Glioblastoma|Renal cell carcinoma, papillary, 1|Squamous cell lung carcinoma|Megalencephaly-capillary malformation-polymicrogyria syndrome|Neoplasm of the large intestine	Pathogenic/Likely pathogenic(Last reviewed: Apr 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013655	3	178936091	3	179218303	13655	28694	rs104886003	NC_000003.12:179218302:G:A
NM_006218.4(PIK3CA):c.2176G>A (p.Glu726Lys)	PIK3CA	E726K	Neoplasm of the large intestine|Squamous cell carcinoma of the head and neck|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Neoplasm of uterine cervix|not provided|Squamous cell lung carcinoma|Breast neoplasm|Inborn genetic diseases	Pathogenic(Last reviewed: Jul 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376476	3	178938934	3	179221146	376476	363355	rs867262025	NC_000003.12:179221145:G:A
NM_006218.4(PIK3CA):c.2740G>A (p.Gly914Arg)	PIK3CA	G914R	Megalencephaly-capillary malformation-polymicrogyria syndrome|Abnormality of cardiovascular system morphology|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000039703	3	178947865	3	179230077	39703	48302	rs587776932	NC_000003.12:179230076:G:A
NM_006218.4(PIK3CA):c.2816A>G (p.Asp939Gly)	PIK3CA	D939G	not provided|Angioosteohypertrophic syndrome|See cases	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV001098323	3	178948044	3	179230256	1098323	1087037		NC_000003.12:179230255:A:G
NM_006218.4(PIK3CA):c.3129G>A (p.Met1043Ile)	PIK3CA	M1043I	Squamous cell carcinoma of the head and neck|Adenocarcinoma of stomach|Neoplasm of the thyroid gland|Malignant neoplasm of body of uterus|Adenoid cystic carcinoma|Non-small cell lung cancer|Transitional cell carcinoma of the bladder|Neoplasm of the large intestine|Breast neoplasm|Megalencephaly-capillary malformation-polymicrogyria syndrome|PIK3CA related overgrowth spectrum|Glioblastoma|Cowden syndrome|Pancreatic adenocarcinoma|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Jun 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000179173	3	178952074	3	179234286	179173	173901	rs121913283	NC_000003.12:179234285:G:A
NM_006218.4(PIK3CA):c.3139C>T (p.His1047Tyr)	PIK3CA	H1047Y	Carcinoma of esophagus|Neoplasm of uterine cervix|Uterine Carcinosarcoma|Malignant tumor of floor of mouth|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Adrenocortical carcinoma|Malignant melanoma of skin|Hepatocellular carcinoma|Squamous cell lung carcinoma|Squamous cell carcinoma of the head and neck|Megalencephaly-capillary malformation-polymicrogyria syndrome|Non-small cell lung cancer|Cowden syndrome|Medulloblastoma|Renal cell carcinoma, papillary, 1|Lung adenocarcinoma|Neoplasm of the large intestine|Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Seborrheic keratosis|Hepatocellular carcinoma|Cowden syndrome 5|Carcinoma of colon|Neoplasm of stomach|Megalencephaly-capillary malformation-polymicrogyria syndrome|Neoplasm of ovary|Familial cancer of breast|Lung carcinoma|Epidermal nevus|Congenital macrodactylia|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of brain|not provided|Glioblastoma|Transitional cell carcinoma of the bladder|Brainstem glioma	Pathogenic(Last reviewed: Sep 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000039705	3	178952084	3	179234296	39705	48304	rs121913281	NC_000003.12:179234295:C:T
NM_006218.4(PIK3CA):c.3140A>T (p.His1047Leu)	PIK3CA	H1047L	Squamous cell lung carcinoma|Glioblastoma|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Adrenocortical carcinoma|Pancreatic adenocarcinoma|Breast neoplasm|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Neoplasm of brain|Neoplasm of ovary|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Malignant melanoma of skin|Carcinoma of esophagus|Megalencephaly-capillary malformation-polymicrogyria syndrome|Hepatocellular carcinoma|PIK3CA related overgrowth spectrum|Renal cell carcinoma, papillary, 1|Hemihypertrophy|Stroke|Macrodactyly of toe|Brainstem glioma|Cowden syndrome 1|Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth|Non-small cell lung cancer|Medulloblastoma|Uterine Carcinosarcoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Breast adenocarcinoma|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013653	3	178952085	3	179234297	13653	28692	rs121913279	NC_000003.12:179234296:A:T
NM_006218.4(PIK3CA):c.3140A>G (p.His1047Arg)	PIK3CA	H1047R	not provided|Breast neoplasm|Neoplasm of brain|Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi|Squamous cell lung carcinoma|Breast adenocarcinoma|Neoplasm of the large intestine|Abnormality of cardiovascular system morphology|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|Brainstem glioma|Medulloblastoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Adrenocortical carcinoma|Non-small cell lung cancer|Lip and oral cavity carcinoma|Congenital macrodactylia|MACRODACTYLY, SOMATIC|Rosette-forming glioneuronal tumor|Uterine Carcinosarcoma|Glioblastoma|OVARIAN CANCER, EPITHELIAL, SOMATIC|Neoplasm of stomach|Neoplasm|Pancreatic adenocarcinoma|PIK3CA related overgrowth spectrum|Carcinoma of colon|Carcinoma of esophagus|Seborrheic keratosis|Malignant melanoma of skin|Hepatocellular carcinoma|Neoplasm of ovary|Renal cell carcinoma, papillary, 1	Pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013652	3	178952085	3	179234297	13652	28691	rs121913279	NC_000003.12:179234296:A:G
NM_000142.5(FGFR3):c.742C>T (p.Arg248Cys)	FGFR3	R248C	Carcinoma of colon|Malignant tumor of testis|Hypochondroplasia|Levy-Hollister syndrome|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Cancer of cervix|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Crouzon syndrome with acanthosis nigricans|Thanatophoric dysplasia type 1|Muenke syndrome|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Carcinoma|Narrow chest|Short stature|Small for gestational age|Bowed humerus|Growth delay|Femoral bowing|Skeletal dysplasia|Bell-shaped thorax|Short ribs|Lower limb undergrowth|Upper limb undergrowth|Disproportionate short-limb short stature|Lethal short-limbed short stature|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Hamartoma|none provided|Squamous cell lung carcinoma|Epidermal nevus|Thanatophoric dysplasia type 1|Skeletal dysplasia with acanthosis nigricans|Lung adenocarcinoma|Multiple myeloma|Cancer of cervix|Craniosynostosis syndrome|Seborrheic keratosis|not provided	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016332	4	1803564	4	1801837	16332	31371	rs121913482	NC_000004.12:1801836:C:T
NM_001163213.1(FGFR3):c.746C>G (p.Ser249Cys)	FGFR3	S249C	Seborrheic keratosis|not provided|Craniosynostosis syndrome|Severe achondroplasia with developmental delay and acanthosis nigricans|Epidermal nevus|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Carcinoma of colon|Cancer of cervix|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Muenke syndrome|Achondroplasia|Malignant tumor of testis|Hypochondroplasia|Cancer of cervix|Urinary bladder cancer|Transitional cell carcinoma of the bladder|Bladder carcinoma|none provided|Carcinoma|Papillary renal cell carcinoma, sporadic|Squamous cell carcinoma of the head and neck|Thanatophoric dysplasia type 1|Squamous cell lung carcinoma	Pathogenic(Last reviewed: Apr 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016339	4	1803568	4	1801841	16339	31378	rs121913483	NC_000004.12:1801840:C:G
NM_000142.5(FGFR3):c.1108G>T (p.Gly370Cys)	FGFR3	G370C, G372C	Thanatophoric dysplasia type 1|Bladder carcinoma|none provided|Epidermal nevus|not provided	Pathogenic(Last reviewed: Apr 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016359	4	1806089	4	1804362	16359	31398	rs121913479	NC_000004.12:1804361:G:T
NM_000142.5(FGFR3):c.1172C>A (p.Ala391Glu)	FGFR3	A391E, A393E	not provided|Craniosynostosis syndrome|Inborn genetic diseases|Carcinoma|Crouzon syndrome with acanthosis nigricans	Pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000016329	4	1806153	4	1804426	16329	31368	rs28931615	NC_000004.12:1804425:C:A
NM_000142.5(FGFR3):c.1948A>G (p.Lys650Glu)	FGFR3	K650E, K652E, K538E, K651E	not provided|none provided|Multiple myeloma|Carcinoma|Thanatophoric dysplasia, type 2|Spermatocytic seminoma	Pathogenic(Last reviewed: Apr 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016331	4	1807889	4	1806162	16331	31370	rs78311289	NC_000004.12:1806161:A:G
NM_000222.3(KIT):c.2446G>C	KIT	D816H, D812H	Dysgerminoma|not provided|Hematologic neoplasm|Germ cell tumor of testis|Melanoma|Gastrointestinal stromal tumor	Pathogenic(Last reviewed: Mar 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000013863	4	55599320	4	54733154	13863	28902	rs121913506	NC_000004.12:54733153:G:C
NM_000038.6(APC):c.847C>T (p.Arg283Ter)	APC	R265*, R283*, R255*, R224*, R258*, R293*	Malignant Colorectal Neoplasm|Carcinoma of colon|Desmoid disease, hereditary|Hepatocellular carcinoma|Familial adenomatous polyposis 1|Neoplasm of stomach|not provided|Familial multiple polyposis syndrome|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Carcinoma of colon	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184999	5	112151204	5	112815507	184999	182336	rs786201856	NC_000005.10:112815506:C:T
NM_000038.6(APC):c.1495C>T (p.Arg499Ter)	APC	R499*, R481*, R373*, R339*, R408*, R474*, R216*, R471*, R517*, R398*, R440*, R458*, R509*	not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1|Carcinoma of colon|Gardner syndrome|Familial multiple polyposis syndrome	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000824	5	112162891	5	112827194	824	15863	rs137854580	NC_000005.10:112827193:C:T
NM_000038.6(APC):c.1660C>T (p.Arg554Ter)	APC	R554*, R536*, R394*, R564*, R453*, R526*, R529*, R271*, R463*, R495*, R572*, R428*, R513*	Colorectal cancer, susceptibility to|Carcinoma of colon|Hepatocellular carcinoma|Familial adenomatous polyposis 1|Desmoid disease, hereditary|Neoplasm of stomach|Familial multiple polyposis syndrome|not provided|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Mar 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000000807	5	112164586	5	112828889	807	15846	rs137854573	NC_000005.10:112828888:C:T
NM_000038.6(APC):c.2626C>T (p.Arg876Ter)	APC	R858*, R876*, R785*, R894*, R593*, R775*, R848*, R886*, R835*, R716*, R750*, R817*, R851*	Hereditary cancer-predisposing syndrome|Carcinoma of colon|Familial adenomatous polyposis 1|not provided|Neoplasm of the large intestine|not specified	Pathogenic(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216014	5	112173917	5	112838220	216014	212414	rs121913333	NC_000005.10:112838219:C:T
NM_000038.6(APC):c.3199C>T (p.Gln1067Ter)	APC	Q1067*, Q1049*, Q1026*, Q1039*, Q784*, Q907*, Q1042*, Q1077*, Q1085*, Q966*, Q976*, Q1008*, Q941*	Neoplasm of stomach|Hereditary cancer-predisposing syndrome|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000000803	5	112174490	5	112838793	803	15842	rs137854571	NC_000005.10:112838792:C:T
NM_000038.6(APC):c.3340C>T (p.Arg1114Ter)	APC	R1096*, R1114*, R1013*, R1023*, R1073*, R1086*, R1089*, R1124*, R1132*, R954*, R988*, R831*, R1055*	Neoplasm of the large intestine|Familial adenomatous polyposis 1|Hereditary cancer-predisposing syndrome|Lung adenocarcinoma|Carcinoma of colon|Familial multiple polyposis syndrome	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000236589	5	112174631	5	112838934	236589	239564	rs121913331	NC_000005.10:112838933:C:T
NM_000038.6(APC):c.3916G>T (p.Glu1306Ter)	APC	E1288*, E1306*, E1180*, E1247*, E1146*, E1265*, E1205*, E1281*, E1324*, E1023*, E1215*, E1278*, E1316*	not provided|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376059	5	112175207	5	112839510	376059	362938	rs121913462	NC_000005.10:112839509:G:T
NM_000038.6(APC):c.4012C>T (p.Gln1338Ter)	APC	Q1338*, Q1320*, Q1237*, Q1279*, Q1297*, Q1348*, Q1212*, Q1055*, Q1178*, Q1310*, Q1313*, Q1356*, Q1247*	Carcinoma of colon|Familial adenomatous polyposis 1|Neoplasm of the large intestine	Pathogenic(Last reviewed: Mar 22, 2016)	criteria provided, multiple submitters, no conflicts	VCV000000801	5	112175303	5	112839606	801	15840	rs121913327	NC_000005.10:112839605:C:T
NM_000038.6(APC):c.4348C>T (p.Arg1450Ter)	APC	R1432*, R1450*, R1167*, R1290*, R1422*, R1425*, R1349*, R1359*, R1409*, R1460*, R1324*, R1391*, R1468*	Hereditary cancer-predisposing syndrome|not provided|Familial multiple polyposis syndrome|Neoplasm of the large intestine|Familial adenomatous polyposis 1	Pathogenic(Last reviewed: Aug 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000194585	5	112175639	5	112839942	194585	191748	rs121913332	NC_000005.10:112839941:C:T
NM_002609.4(PDGFRB):c.1681C>T (p.Arg561Cys)	PDGFRB	R561C, R497C, R400C	Premature aging syndrome, Penttinen type|Basal ganglia calcification, idiopathic, 4|Kosaki overgrowth syndrome|Infantile myofibromatosis|Infantile myofibromatosis|not provided|Infantile myofibromatosis 1|Basal ganglia calcification, idiopathic, 4	Pathogenic(Last reviewed: Jul 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000055848	5	149505134	5	150125571	55848	70502	rs367543286	NC_000005.10:150125570:G:A
NM_000245.4(MET):c.3274G>A (p.Val1092Ile)	MET	V1110I, V1092I, V662I	Neoplasm|Renal cell carcinoma|Carcinoma|Renal cell carcinoma, papillary, 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186141	7	116417457	7	116777403	186141	182676	rs786202724	NC_000007.14:116777402:G:A
NM_000245.4(MET):c.3281A>G (p.His1094Arg)	MET	H1112R, H1094R, H664R	not provided|Renal cell carcinoma|Kidney Carcinoma|Renal cell carcinoma, papillary, 1	Pathogenic(Last reviewed: Jul 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013887	7	116417464	7	116777410	13887	28926	rs121913243	NC_000007.14:116777409:A:G
NM_004333.6(BRAF):c.1799T>G (p.Val600Gly)	BRAF	V600G	Melanoma|Rasopathy|not provided|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Jun 25, 2020)	reviewed by expert panel	VCV000040389	7	140453136	7	140753336	40389	48859	rs113488022	NC_000007.14:140753335:A:C
NM_001374258.1(BRAF):c.1919T>A (p.Val640Glu)	BRAF	V600E, V512E, V578E, V603E, V548E, V566E, V563E, V640E	Carcinoma of colon|Malignant neoplastic disease|Melanoma|Cystic epithelial invagination containing papillae lined by columnar epithelium|Colonic neoplasm|Papillary renal cell carcinoma, sporadic|Neoplasm|Neoplasm of the large intestine|Glioblastoma|Cardio-facio-cutaneous syndrome|Nephroblastoma|Colorectal cancer|Brainstem glioma|Trametinib-Dabrafenib Response|Vemurafenib-Cobimetinib Response|Germ cell tumor, nonseminomatous|Lung adenocarcinoma|Neoplasm of brain|Multiple myeloma|Gastrointestinal stromal tumor|Neoplasm of ovary|Papillary thyroid carcinoma|Malignant melanoma of skin|Astrocytoma, low-grade, somatic|Non-small cell lung cancer|Cerebral arteriovenous malformation|Lung carcinoma|not provided|Squamous cell carcinoma of the head and neck	Pathogenic, drug response, other(Last reviewed: Jul 11, 2014)	criteria provided, multiple submitters, no conflicts	VCV000013961	7	140453136	7	140753336	13961	29000	rs113488022	NC_000007.14:140753335:A:T
NM_004333.6(BRAF):c.1796C>T (p.Thr599Ile)	BRAF	T599I	Noonan syndrome|Neoplasm|not provided|Melanoma|Rasopathy	Pathogenic(Last reviewed: Mar 24, 2020)	reviewed by expert panel	VCV000040388	7	140453139	7	140753339	40388	48858	rs121913375	NC_000007.14:140753338:G:A
NM_001374258.1(BRAF):c.1909C>G (p.Leu637Val)	BRAF	L597V, L509V, L545V, L563V, L600V, L637V, L560V, L575V	Non-small cell lung cancer|Neoplasm|not provided|Noonan syndrome 1|Noonan syndrome 7|Melanoma|Lung carcinoma|Cardio-facio-cutaneous syndrome|Noonan syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013969	7	140453146	7	140753346	13969	29008	rs121913369	NC_000007.14:140753345:G:C
NM_001374258.1(BRAF):c.1907G>T (p.Gly636Val)	BRAF	G596V, G508V, G599V, G544V, G559V, G574V, G562V, G636V	Inborn genetic diseases|Cardiofaciocutaneous syndrome 1|not provided|Lung adenocarcinoma|Glioblastoma|Multiple myeloma|Transitional cell carcinoma of the bladder|Rasopathy|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000040387	7	140453148	7	140753348	40387	48857	rs397507483	NC_000007.14:140753347:C:A
NM_004333.6(BRAF):c.1785T>A (p.Phe595Leu)	BRAF	F595L	Melanoma|not provided|Rasopathy	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180789	7	140453150	7	140753350	180789	179094	rs121913341	NC_000007.14:140753349:A:T
NM_001374258.1(BRAF):c.1905T>G (p.Phe635Leu)	BRAF	F595L, F573L, F598L, F543L, F635L, F507L, F558L, F561L	Neoplasm|not provided|Cardio-facio-cutaneous syndrome|Rasopathy|Melanoma	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000177672	7	140453150	7	140753350	177672	174042	rs121913341	NC_000007.14:140753349:A:C
NM_001374258.1(BRAF):c.1903T>C (p.Phe635Leu)	BRAF	F595L, F573L, F598L, F543L, F561L, F635L, F507L, F558L	Melanoma|not provided|Cardiofaciocutaneous syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, multiple submitters, no conflicts	VCV000202193	7	140453152	7	140753352	202193	198628	rs794729219	NC_000007.14:140753351:A:G
NM_004333.6(BRAF):c.1781A>T (p.Asp594Val)	BRAF	D594V	Cardio-facio-cutaneous syndrome|Melanoma|Neoplasm of the large intestine|Rasopathy	Pathogenic(Last reviewed: May 18, 2020)	reviewed by expert panel	VCV000375946	7	140453154	7	140753354	375946	362825	rs121913338	NC_000007.14:140753353:T:A
NM_001374258.1(BRAF):c.1526G>A (p.Gly509Glu)	BRAF	G469E, G381E, G447E, G417E, G432E, G472E, G435E, G509E	not provided|Melanoma|Adenocarcinoma of prostate|Neoplasm of the large intestine|Rasopathy|Cardio-facio-cutaneous syndrome|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Multiple myeloma|Malignant melanoma of skin|not specified|Squamous cell lung carcinoma|Cardiofaciocutaneous syndrome 1	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000013974	7	140481402	7	140781602	13974	29013	rs121913355	NC_000007.14:140781601:C:T
NM_001374258.1(BRAF):c.1511G>T (p.Gly504Val)	BRAF	G464V, G427V, G376V, G442V, G412V, G430V, G467V, G504V	Neoplasm|none provided|Non-small cell lung cancer|Breast neoplasm|Rasopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000040364	7	140481417	7	140781617	40364	48834	rs121913348	NC_000007.14:140781616:C:A
NM_001374258.1(BRAF):c.1511G>A (p.Gly504Glu)	BRAF	G464E, G427E, G442E, G504E, G412E, G467E, G376E, G430E	Neoplasm|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|Carcinoma of colon|not provided|Chronic lymphocytic leukemia|Rasopathy	Pathogenic(Last reviewed: Mar 9, 2020)	reviewed by expert panel	VCV000013964	7	140481417	7	140781617	13964	29003	rs121913348	NC_000007.14:140781616:C:T
NM_004333.6(BRAF):c.1390G>A (p.Gly464Arg)	BRAF	G464R	Melanoma|Cardio-facio-cutaneous syndrome|Rasopathy|not provided	Pathogenic(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000372572	7	140481418	7	140781618	372572	359643	rs121913349	NC_000007.14:140781617:C:T
NM_058246.4(DNAJB6):c.265T>A (p.Phe89Ile)	DNAJB6	F89I	not provided|Limb-girdle muscular dystrophy, type 1E	Pathogenic(Last reviewed: Jun 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000031531	7	157160096	7	157367402	31531	40204	rs387907150	NC_000007.14:157367401:T:A
NM_004817.4(TJP2):c.2209G>A (p.Gly737Ser)	TJP2	G712S, G714S, G737S, G741S, G768S	Melnick-Fraser syndrome|Progressive familial intrahepatic cholestasis 4	Pathogenic/Likely pathogenic(Last reviewed: Apr 12, 2021)	criteria provided, multiple submitters, no conflicts	VCV000805838	9	71852823	9	69237907	805838	794160	rs139314808	NC_000009.12:69237906:G:A
NM_017433.5(MYO3A):c.2090T>G (p.Leu697Trp)	MYO3A	L697W	Nonsyndromic hearing loss and deafness|nonsyndromic sensorineural hearing loss|not provided	Pathogenic(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000617675	10	26414513	10	26125584	617675	609078	rs1564573788	NC_000010.11:26125583:T:G
NM_020975.6(RET):c.1826G>A (p.Cys609Tyr)	RET	C609Y, C355Y	not provided|none provided|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Familial medullary thyroid carcinoma|MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013933	10	43609070	10	43113622	13933	28972	rs77939446	NC_000010.11:43113621:G:A
NM_020975.6(RET):c.1852T>C (p.Cys618Arg)	RET	C618R, C364R	Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 1|not provided	Pathogenic(Last reviewed: Apr 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013929	10	43609096	10	43113648	13929	28968	rs76262710	NC_000010.11:43113647:T:C
NM_020975.6(RET):c.1853G>A (p.Cys618Tyr)	RET	C618Y, C364Y	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 4|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2b	Pathogenic(Last reviewed: Jan 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000024901	10	43609097	10	43113649	24901	36242	rs79781594	NC_000010.11:43113648:G:A
NM_020975.6(RET):c.1859G>A (p.Cys620Tyr)	RET	C620Y, C366Y	Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|not provided|Multiple endocrine neoplasia, type 2|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 1|Hirschsprung disease|none provided	Pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013916	10	43609103	10	43113655	13916	28955	rs77503355	NC_000010.11:43113654:G:A
NM_020975.6(RET):c.1900T>C (p.Cys634Arg)	RET	C634R, C380R	not provided|Medullary thyroid carcinoma|Thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2b|not specified|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 4|Pheochromocytoma	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013917	10	43609948	10	43114500	13917	28956	rs75076352	NC_000010.11:43114499:T:C
NM_020975.6(RET):c.1901G>A (p.Cys634Tyr)	RET	C634Y, C380Y	not provided|Neoplasm|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2b|not specified|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 4|Pheochromocytoma	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013909	10	43609949	10	43114501	13909	28948	rs75996173	NC_000010.11:43114500:G:A
NM_020975.6(RET):c.1902C>G (p.Cys634Trp)	RET	C634W, C380W	Neoplasm of the thyroid gland|not provided|Multiple endocrine neoplasia, type 2|Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|Pheochromocytoma|Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: May 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013918	10	43609950	10	43114502	13918	28957	rs77709286	NC_000010.11:43114501:C:G
NM_020975.6(RET):c.2304G>C (p.Glu768Asp)	RET	E768D, E514D	Neoplasm|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2|Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 4|Multiple endocrine neoplasia, type 1|none provided|Familial medullary thyroid carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013931	10	43613840	10	43118392	13931	28970	rs78014899	NC_000010.11:43118391:G:C
NM_020975.6(RET):c.2410G>C (p.Val804Leu)	RET	V804L, V550L	Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 4|not provided|Multiple endocrine neoplasia, type 2a|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2b	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000038613	10	43614996	10	43119548	38613	47217	rs79658334	NC_000010.11:43119547:G:C
NM_020975.6(RET):c.2671T>G (p.Ser891Ala)	RET	S891A, S637A	Multiple endocrine neoplasia, type 1|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia, type 2a|not provided|Multiple endocrine neoplasia, type 2|Familial medullary thyroid carcinoma|Medullary thyroid carcinoma|Hereditary cancer-predisposing syndrome|not specified|Multiple endocrine neoplasia, type 4	Pathogenic(Last reviewed: Sep 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013951	10	43615592	10	43120144	13951	28990	rs75234356	NC_000010.11:43120143:T:G
NM_020975.6(RET):c.2753T>C (p.Met918Thr)	RET	M918T, M664T	Neoplasm of the thyroid gland|Inborn genetic diseases|Gingival enlargement|Constipation|Short stature|Hypothyroidism|Tetralogy of Fallot|Thick vermilion border|Joint hypermobility|Hypertelorism|Medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2|Multiple endocrine neoplasia, type 1|Familial medullary thyroid carcinoma|Multiple endocrine neoplasia, type 2b|not specified|Thyroid carcinoma, sporadic medullary|Multiple endocrine neoplasia, type 2a|Hirschsprung disease 1|not provided|Multiple endocrine neoplasia, type 4|Pheochromocytoma	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013919	10	43617416	10	43121968	13919	28958	rs74799832	NC_000010.11:43121967:T:C
NM_001304718.2(PTEN):c.-363C>G	PTEN	R130G, R303G	Malignant tumor of floor of mouth|Uterine Carcinosarcoma|Malignant melanoma of skin|Neoplasm of the large intestine|Small cell lung carcinoma|Squamous cell carcinoma of the head and neck|Endometrial carcinoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Squamous cell lung carcinoma|Glioblastoma|PTEN hamartoma tumor syndrome|Breast neoplasm|Neoplasm of ovary|Renal cell carcinoma, papillary, 1	Pathogenic(Last reviewed: Jun 25, 2019)	reviewed by expert panel	VCV000375958	10	89692904	10	87933147	375958	362837	rs121909224	NC_000010.11:87933146:C:G
NM_000314.7(PTEN):c.388C>T (p.Arg130Ter)	PTEN	R130*, R303*	Neoplasm of ovary|Rhabdomyosarcoma (disease)|Hereditary cancer-predisposing syndrome|Abnormality of cardiovascular system morphology|not provided|Neoplasm of brain|none provided|PTEN hamartoma tumor syndrome|Macrocephaly/autism syndrome|Glioma susceptibility 2|Cowden syndrome 1	Pathogenic(Last reviewed: Jan 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000007819	10	89692904	10	87933147	7819	22858	rs121909224	NC_000010.11:87933146:C:T
NM_000314.8(PTEN):c.389G>T	PTEN	R130L, R303L	Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Malignant melanoma of skin|Squamous cell lung carcinoma|not provided|Adenocarcinoma of stomach|Breast neoplasm|Renal cell carcinoma, papillary, 1|Uterine Carcinosarcoma|Glioblastoma|Small cell lung carcinoma|Neoplasm of uterine cervix|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376509	10	89692905	10	87933148	376509	363388	rs121909229	NC_000010.11:87933147:G:T
NM_000314.7(PTEN):c.389G>C (p.Arg130Pro)	PTEN	R130P, R303P	Renal cell carcinoma, papillary, 1|PTEN hamartoma tumor syndrome|Glioblastoma|Hereditary cancer-predisposing syndrome|Uterine Carcinosarcoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Small cell lung carcinoma|Squamous cell lung carcinoma|Malignant melanoma of skin|Breast neoplasm|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine	Pathogenic(Last reviewed: Nov 22, 2019)	reviewed by expert panel	VCV000142018	10	89692905	10	87933148	142018	151732	rs121909229	NC_000010.11:87933147:G:C
NM_000314.7(PTEN):c.389G>A (p.Arg130Gln)	PTEN	R130Q, R303Q	Cowden syndrome 1|PTEN hamartoma tumor syndrome|not provided|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Uterine Carcinosarcoma|Neoplasm|Neoplasm of the large intestine|Glioblastoma|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of ovary|Malignant melanoma of skin|Renal cell carcinoma, papillary, 1|Squamous cell lung carcinoma|Small cell lung carcinoma	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	VCV000007829	10	89692905	10	87933148	7829	22868	rs121909229	NC_000010.11:87933147:G:A
NM_000314.7(PTEN):c.403A>G (p.Ile135Val)	PTEN	I135V, I308V	not provided|PTEN hamartoma tumor syndrome|Neoplasm of ovary|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000142287	10	89692919	10	87933162	142287	152001	rs587782360	NC_000010.11:87933161:A:G
NM_000314.8(PTEN):c.406T>C (p.Cys136Arg)	PTEN	C136R, C309R	Mediastinal germ cell tumor|Acute megakaryoblastic leukemia|Neoplasm of ovary|Cowden syndrome|Hereditary cancer-predisposing syndrome|not provided|PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Sep 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183726	10	89692922	10	87933165	183726	183028	rs786201044	NC_000010.11:87933164:T:C
NM_000314.7(PTEN):c.509G>T (p.Ser170Ile)	PTEN	S170I, S343I	Neoplasm of ovary|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233590	10	89711891	10	87952134	233590	233855	rs876660507	NC_000010.11:87952133:G:T
NM_000314.7(PTEN):c.517C>T (p.Arg173Cys)	PTEN	R173C, R346C	not specified|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of brain|PTEN hamartoma tumor syndrome|Glioma susceptibility 2|Meningioma, familial|VACTERL association with hydrocephalus|Macrocephaly/autism syndrome|Cowden syndrome 1|Malignant tumor of prostate|VACTERL association with hydrocephalus|Macrocephaly/autism syndrome|Cowden syndrome 1|PTEN hamartoma tumor syndrome	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	VCV000189500	10	89711899	10	87952142	189500	187363	rs121913293	NC_000010.11:87952141:C:T
NM_000314.8(PTEN):c.518G>A (p.Arg173His)	PTEN	R173H, R346H	Neoplasm of brain|not provided|PTEN hamartoma tumor syndrome	Pathogenic/Likely pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376032	10	89711900	10	87952143	376032	362911	rs121913294	NC_000010.11:87952142:G:A
NM_000314.8(PTEN):c.633C>A	PTEN	C211*, C14*, C384*	PTEN hamartoma tumor syndrome|Hereditary cancer-predisposing syndrome|Cowden syndrome 1|Melanoma|not provided	Pathogenic(Last reviewed: Nov 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007836	10	89712015	10	87952258	7836	22875	rs121909232	NC_000010.11:87952257:C:A
NM_000314.7(PTEN):c.697C>T (p.Arg233Ter)	PTEN	R233*, R406*, R36*	Glioblastoma|Cowden syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of ovary|Abnormality of cardiovascular system morphology|PTEN hamartoma tumor syndrome|Cowden syndrome 1|Macrocephaly/autism syndrome|Non-small cell lung cancer|none provided|Neoplasm of the large intestine	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007813	10	89717672	10	87957915	7813	22852	rs121909219	NC_000010.11:87957914:C:T
NM_000314.7(PTEN):c.740T>G (p.Leu247Ter)	PTEN	L247*, L50*, L420*	Hereditary cancer-predisposing syndrome|not provided|Neoplasm of ovary	Pathogenic(Last reviewed: Feb 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000428210	10	89717715	10	87957958	428210	419746	rs1057519368	NC_000010.11:87957957:T:G
NM_000314.8(PTEN):c.1003C>T (p.Arg335Ter)	PTEN	R335*, R508*, R138*	Cowden syndrome|VACTERL association with hydrocephalus|Meningioma, familial|Macrocephaly/autism syndrome|Glioma susceptibility 2|Cowden syndrome 1|PTEN hamartoma tumor syndrome|Malignant tumor of prostate|not provided|Neoplasm of ovary|Macrocephaly/autism syndrome|Proteus-like syndrome|Cowden syndrome 1|Hereditary cancer-predisposing syndrome|Neoplasm of brain|PTEN hamartoma tumor syndrome|PTEN-related disorder|Macrocephaly/autism syndrome|Cowden syndrome 1|Inborn genetic diseases	Pathogenic(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007833	10	89720852	10	87961095	7833	22872	rs121909231	NC_000010.11:87961094:C:T
NM_000314.7(PTEN):c.1026+1G>A	PTEN		not provided|Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|Cowden syndrome 1	Pathogenic(Last reviewed: Oct 18, 2017)	reviewed by expert panel	VCV000183722	10	89720876	10	87961119	183722	183060	rs786201041	NC_000010.11:87961118:G:A
NM_000314.7(PTEN):c.1026+2T>G	PTEN		Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428197	10	89720877	10	87961120	428197	419772	rs1114167624	NC_000010.11:87961119:T:G
NM_000314.7(PTEN):c.1027-1G>A	PTEN		Hereditary cancer-predisposing syndrome|PTEN hamartoma tumor syndrome|not provided|Neoplasm of ovary	Pathogenic(Last reviewed: Jun 25, 2019)	reviewed by expert panel	VCV000372482	10	89725043	10	87965286	372482	359852	rs1057517809	NC_000010.11:87965285:G:A
NM_000141.5(FGFR2):c.1694A>G (p.Glu565Gly)	FGFR2	E565G, E566G, E337G, E477G, E449G, E450G, E448G, E453G, E476G, E563G	Pfeiffer syndrome|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000374823	10	123256215	10	121496701	374823	361707	rs121918506	NC_000010.11:121496700:T:C
NM_000141.5(FGFR2):c.1124A>G (p.Tyr375Cys)	FGFR2	Y375C, Y376C, Y263C, Y147C, Y286C, Y287C, Y260C	Endometrial carcinoma|Beare-Stevenson cutis gyrata syndrome|Endometrial neoplasm|not provided|FGFR2 related craniosynostosis|Saethre-Chotzen syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Pfeiffer syndrome|Bent bone dysplasia syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Levy-Hollister syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Neoplasm of stomach	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013277	10	123274794	10	121515280	13277	28316	rs121913478	NC_000010.11:121515279:T:C
NM_000141.5(FGFR2):c.1025G>A (p.Cys342Tyr)	FGFR2	C342Y, C253Y, C227Y, C114Y	FGFR2 related craniosynostosis|Levy-Hollister syndrome|Bent bone dysplasia syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Pfeiffer syndrome|Acrocephalosyndactyly type I|Neoplasm of stomach|Saethre-Chotzen syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|not provided|Crouzon syndrome|Pfeiffer syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013263	10	123276892	10	121517378	13263	28302	rs121918487	NC_000010.11:121517377:C:T
NM_000141.5(FGFR2):c.799T>C (p.Ser267Pro)	FGFR2	S267P, S152P, S178P, S39P	Crouzon syndrome|Pfeiffer syndrome|FGFR2 related craniosynostosis|Neoplasm of stomach|not provided	Pathogenic(Last reviewed: May 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013290	10	123279633	10	121520119	13290	28329	rs121918505	NC_000010.11:121520118:A:G
NM_000141.5(FGFR2):c.758C>G (p.Pro253Arg)	FGFR2	P253R, P138R, P164R, P25R	not provided|Head and Neck Neoplasms|FGFR2 related craniosynostosis|Levy-Hollister syndrome|Bent bone dysplasia syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Crouzon syndrome|Pfeiffer syndrome|Acrocephalosyndactyly type I|Neoplasm of stomach|Saethre-Chotzen syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Acrocephalosyndactyly type I	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013273	10	123279674	10	121520160	13273	28312	rs77543610	NC_000010.11:121520159:G:C
NM_000141.5(FGFR2):c.755C>G (p.Ser252Trp)	FGFR2	S252W, S137W, S163W, S24W	Endometrial carcinoma|Acrocephalosyndactyly type I|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Acrocephalosyndactyly|Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation|Endometrial neoplasm|Uterine Carcinosarcoma|FGFR2 related craniosynostosis|Saethre-Chotzen syndrome|Scaphocephaly, maxillary retrusion, and mental retardation|Pfeiffer syndrome|Bent bone dysplasia syndrome|Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis|Crouzon syndrome|Levy-Hollister syndrome|Jackson-Weiss syndrome|Beare-Stevenson cutis gyrata syndrome|Acrocephalosyndactyly type I|Neoplasm of stomach|not provided	Pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013272	10	123279677	10	121520163	13272	28311	rs79184941	NC_000010.11:121520162:G:C
NM_003282.4(TNNI2):c.466C>T (p.Arg156Ter)	TNNI2	R156*	not provided|Distal arthrogryposis|Congenital finger flexion contractures|Ulnar deviation of the wrist|Calcaneovalgus deformity|Distal arthrogryposis type 2B	Pathogenic(Last reviewed: Sep 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012436	11	1862698	11	1841468	12436	27475	rs104894312	NC_000011.10:1841467:C:T
NM_003282.4(TNNI2):c.521G>A (p.Arg174Gln)	TNNI2	R174Q	Distal arthrogryposis type 2B|not provided	Pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012435	11	1862753	11	1841523	12435	27474	rs104894311	NC_000011.10:1841522:G:A
NM_000256.3(MYBPC3):c.821+1G>A	MYBPC3		Cardiovascular phenotype|Primary dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy|Primary familial hypertrophic cardiomyopathy|not provided	Pathogenic(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000042791	11	47369407	11	47347856	42791	51961	rs397516073	NC_000011.10:47347855:C:T
NM_000256.3(MYBPC3):c.772G>A (p.Glu258Lys)	MYBPC3	E258K	Cardiomyopathy|Familial hypertrophic cardiomyopathy 4|Familial hypertrophic cardiomyopathy 4|Left ventricular noncompaction 10|not provided|Hypertrophic cardiomyopathy|Cardiovascular phenotype|Primary familial hypertrophic cardiomyopathy	Pathogenic/Likely pathogenic(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000042792	11	47369975	11	47348424	42792	51962	rs397516074	NC_000011.10:47348423:C:T
NM_000244.3(MEN1):c.1594C>T (p.Arg532Ter)	MEN1	R527*, R532*, R569*, R492*	Metastatic pancreatic neuroendocrine tumours|Multiple endocrine neoplasia, type 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016688	11	64572060	11	64804588	16688	31727	rs104894261	NC_000011.10:64804587:G:A
NM_000244.3(MEN1):c.798+1G>A	MEN1		Metastatic pancreatic neuroendocrine tumours|not specified|Hereditary cancer-predisposing syndrome|Multiple endocrine neoplasia, type 1	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428081	11	64575023	11	64807551	428081	419830	rs794728652	NC_000011.10:64807550:C:T
NM_003002.4(SDHD):c.242C>T (p.Pro81Leu)	SDHD	P81L, P42L	Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 1|Mitochondrial complex II deficiency, nuclear type 1|Pheochromocytoma|Carney-Stratakis syndrome|Paragangliomas 1|Cowden syndrome 3|not provided|Paragangliomas 1 with sensorineural hearing loss|Paragangliomas 1|Pheochromocytoma|Hereditary cancer-predisposing syndrome|Hereditary Paraganglioma-Pheochromocytoma Syndromes|not specified	Pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000006896	11	111959663	11	112088939	6896	21935	rs80338844	NC_000011.10:112088938:C:T
NM_005188.3(CBL):c.1111T>C (p.Tyr371His)	CBL	Y371H	not provided|Noonan syndrome-like disorder with juvenile myelomonocytic leukemia|Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia|Juvenile myelomonocytic leukemia|Hematologic neoplasm|Rasopathy	Pathogenic(Last reviewed: Dec 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013811	11	119148891	11	119278181	13811	28850	rs267606706	NC_000011.10:119278180:T:C
NM_005188.4(CBL):c.1228-2A>G	CBL		Juvenile myelomonocytic leukemia|Noonan syndrome|Malignant germ cell tumor of ovary|Rasopathy|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000177959	11	119149218	11	119278508	177959	175345	rs727504426	NC_000011.10:119278507:A:G
NM_004985.5(KRAS):c.40G>A (p.Val14Ile)	KRAS	V14I	Rasopathy|Noonan syndrome|Noonan syndrome 3|none provided|Endometrial carcinoma|Cardio-facio-cutaneous syndrome|Noonan syndrome|not provided|Inborn genetic diseases	Pathogenic(Last reviewed: Apr 3, 2017)	reviewed by expert panel	VCV000012589	12	25398279	12	25245345	12589	27628	rs104894365	NC_000012.12:25245344:C:T
NM_004985.5(KRAS):c.38G>A (p.Gly13Asp)	KRAS	G13D	OCULOECTODERMAL SYNDROME, SOMATIC|Neoplasm of the thyroid gland|Neoplasm of the large intestine|Inborn genetic diseases|Juvenile myelomonocytic leukemia|Nevus sebaceous|Neoplasm of ovary|RAS-associated autoimmune leukoproliferative disorder|Non-small cell lung cancer|Breast adenocarcinoma|not provided|Acute myeloid leukemia	Pathogenic(Last reviewed: Feb 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012580	12	25398281	12	25245347	12580	27619	rs112445441	NC_000012.12:25245346:C:T
NM_004985.5(KRAS):c.37G>T (p.Gly13Cys)	KRAS	G13C	RAS-associated autoimmune leukoproliferative disorder|Neoplasm of the large intestine|not provided|Non-small cell lung cancer	Pathogenic(Last reviewed: Jan 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000045123	12	25398282	12	25245348	45123	54290	rs121913535	NC_000012.12:25245347:C:A
NM_004985.5(KRAS):c.35G>T (p.Gly12Val)	KRAS	G12V	Juvenile myelomonocytic leukemia|Carcinoma of pancreas|Nevus sebaceous|Cerebral arteriovenous malformation|not provided|Non-small cell lung cancer|Acute myeloid leukemia|Neoplasm of ovary|Neoplasm of the thyroid gland|Neoplasm of the large intestine	Pathogenic(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012583	12	25398284	12	25245350	12583	27622	rs121913529	NC_000012.12:25245349:C:A
NM_004985.5(KRAS):c.35G>A (p.Gly12Asp)	KRAS	G12D	Nevus sebaceous|Epidermal nevus syndrome|Primary low grade serous adenocarcinoma of ovary|Cerebral arteriovenous malformation|Lung carcinoma|not provided|Neoplasm of the large intestine|Neoplasm of the thyroid gland|Neoplasm of stomach|Non-small cell lung cancer|Epidermal nevus|Vascular Tumors Including Pyogenic Granuloma|Rasopathy|RAS-associated autoimmune leukoproliferative disorder|Juvenile myelomonocytic leukemia|Neoplasm of ovary|Carcinoma of pancreas|Acute myeloid leukemia	Pathogenic(Last reviewed: Jun 30, 2017)	criteria provided, multiple submitters, no conflicts	VCV000012582	12	25398284	12	25245350	12582	27621	rs121913529	NC_000012.12:25245349:C:T
NM_004985.5(KRAS):c.34G>A (p.Gly12Ser)	KRAS	G12S	Neoplasm of the thyroid gland|Neoplasm of the large intestine|Juvenile myelomonocytic leukemia|Neoplasm of stomach|Neoplasm of ovary|Non-small cell lung cancer|not provided	Pathogenic(Last reviewed: May 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000012584	12	25398285	12	25245351	12584	27623	rs121913530	NC_000012.12:25245350:C:T
NM_003482.3(KMT2D):c.12844C>T (p.Arg4282Ter)	KMT2D	R4282*	Kabuki syndrome 1|not provided|Multiple myeloma	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000372805	12	49425644	12	49031861	372805	359952	rs1057517992	NC_000012.12:49031860:G:A
NM_000020.2(ACVRL1):c.1435C>T (p.Arg479Ter)	ACVRL1	R479*	Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2|not provided|Hereditary hemorrhagic telangiectasia type 1	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372722	12	52314600	12	51920816	372722	360048	rs1057517944	NC_000012.12:51920815:C:T
NM_000075.4(CDK4):c.70C>T (p.Arg24Cys)	CDK4	R24C	Multiple myeloma|Malignant melanoma of skin|Cutaneous malignant melanoma 3|Hereditary cancer-predisposing syndrome|Lung adenocarcinoma|not provided|Hereditary melanoma	Pathogenic(Last reviewed: Apr 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000016928	12	58145431	12	57751648	16928	31967	rs11547328	NC_000012.12:57751647:G:A
NM_002834.5(PTPN11):c.181G>T (p.Asp61Tyr)	PTPN11	D61Y, D60Y	not provided|Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Jul 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000228392	12	112888165	12	112450361	228392	230257	rs397507510	NC_000012.12:112450360:G:T
NM_002834.5(PTPN11):c.214G>A (p.Ala72Thr)	PTPN11	A72T, A71T	Noonan syndrome 1|Rasopathy|Chronic lymphocytic leukemia|Neuroblastoma|not provided|Acute myeloid leukemia|Neoplasm of brain|Juvenile myelomonocytic leukemia|Noonan syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000177754	12	112888198	12	112450394	177754	175540	rs121918453	NC_000012.12:112450393:G:A
NM_002834.5(PTPN11):c.227A>G (p.Glu76Gly)	PTPN11	E76G, E75G	Neoplasm of the large intestine|Astrocytoma|not provided|Squamous cell lung carcinoma|Multiple myeloma|Neuroblastoma|Juvenile myelomonocytic leukemia	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000013338	12	112888211	12	112450407	13338	28377	rs121918465	NC_000012.12:112450406:A:G
NM_002834.4(PTPN11):c.227A>T (p.Glu76Val)	PTPN11	E76V	Juvenile myelomonocytic leukemia|not provided|Rasopathy	Pathogenic(Last reviewed: May 31, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013337	12	112888211	12	112450407	13337	28376	rs121918465	NC_000012.12:112450406:A:T
NM_002834.5(PTPN11):c.854T>C (p.Phe285Ser)	PTPN11	F285S, F284S	Rasopathy|Early T cell progenitor acute lymphoblastic leukemia|Non-immune hydrops fetalis|Noonan syndrome|not provided|Noonan syndrome 1	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013335	12	112915455	12	112477651	13335	28374	rs121918463	NC_000012.12:112477650:T:C
NM_000059.4(BRCA2):c.250C>T (p.Gln84Ter)	BRCA2	Q84*	not provided|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000051298	13	32893396	13	32319259	51298	65966	rs80358515	NC_000013.11:32319258:C:T
NM_000059.4(BRCA2):c.274C>T (p.Gln92Ter)	BRCA2	Q92*	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Breast-ovarian cancer, familial 2|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037799	13	32893420	13	32319283	37799	46355	rs80358529	NC_000013.11:32319282:C:T
NM_000059.4(BRCA2):c.1261C>T (p.Gln421Ter)	BRCA2	Q421*	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000051092	13	32906876	13	32332739	51092	65760	rs80358419	NC_000013.11:32332738:C:T
NM_000059.4(BRCA2):c.3109C>T (p.Gln1037Ter)	BRCA2	Q1037*	Hereditary cancer-predisposing syndrome|Familial cancer of breast|Medulloblastoma|Pancreatic cancer 2|Fanconi anemia, complementation group D1|Malignant tumor of prostate|Wilms tumor 1|Breast-ovarian cancer, familial 2|Glioma susceptibility 3|Breast-ovarian cancer, familial 2|Malignant tumor of breast|Hereditary breast and ovarian cancer syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037819	13	32911601	13	32337464	37819	46375	rs80358557	NC_000013.11:32337463:C:T
NM_000059.3(BRCA2):c.6385G>T (p.Glu2129Ter)	BRCA2	E2129*	Neoplasm of ovary|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000266943	13	32914877	13	32340740	266943	261356	rs886040653	NC_000013.11:32340739:G:T
NM_000059.4(BRCA2):c.6952C>T (p.Arg2318Ter)	BRCA2	R2318*	Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Breast neoplasm|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Familial cancer of breast|not provided	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000038076	13	32920978	13	32346841	38076	46632	rs80358920	NC_000013.11:32346840:C:T
NM_000059.4(BRCA2):c.7007G>T (p.Arg2336Leu)	BRCA2	R2336L	Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial 2	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000052242	13	32921033	13	32346896	52242	66910	rs28897743	NC_000013.11:32346895:G:T
NM_000059.4(BRCA2):c.7471C>T (p.Gln2491Ter)	BRCA2	Q2491*	Malignant tumor of breast|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000052339	13	32930600	13	32356463	52339	67007	rs80358971	NC_000013.11:32356462:C:T
NM_000059.4(BRCA2):c.7878G>A (p.Trp2626Ter)	BRCA2	W2626*	Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Malignant tumor of breast|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000038124	13	32936732	13	32362595	38124	46680	rs80359013	NC_000013.11:32362594:G:A
NM_000059.3(BRCA2):c.7976+1G>A	BRCA2		Breast-ovarian cancer, familial 2|not provided|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000052452	13	32936831	13	32362694	52452	67120	rs81002873	NC_000013.11:32362693:G:A
NM_000059.3(BRCA2):c.8490G>A (p.Trp2830Ter)	BRCA2	W2830*	Breast-ovarian cancer, familial 2|Familial cancer of breast|not provided	Pathogenic(Last reviewed: Oct 18, 2016)	reviewed by expert panel	VCV000155722	13	32945095	13	32370958	155722	165476	rs587776351	NC_000013.11:32370957:G:A
NM_000321.2(RB1):c.380+1G>A	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428727	13	48916851	13	48342715	428727	420514	rs1131690902	NC_000013.11:48342714:G:A
NM_000321.3(RB1):c.763C>T	RB1	R255*	Hereditary cancer-predisposing syndrome|Retinoblastoma|not provided	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000126820	13	48936995	13	48362859	126820	132330	rs587778842	NC_000013.11:48362858:C:T
NM_000321.3(RB1):c.958C>T	RB1	R320*	not provided|Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Jan 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000126824	13	48941648	13	48367512	126824	132334	rs121913300	NC_000013.11:48367511:C:T
NM_000321.2(RB1):c.1049+1G>A	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic/Likely pathogenic(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000126827	13	48941740	13	48367604	126827	132337	rs587776782	NC_000013.11:48367603:G:A
NM_000321.2(RB1):c.1072C>T (p.Arg358Ter)	RB1	R358*	Retinoblastoma|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000013076	13	48942685	13	48368549	13076	28115	rs121913301	NC_000013.11:48368548:C:T
NM_000321.3(RB1):c.1215+1G>A	RB1		Hereditary cancer-predisposing syndrome|Urinary bladder cancer|Osteosarcoma|Small cell lung carcinoma|Retinoblastoma|Retinoblastoma	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000126832	13	48947629	13	48373493	126832	132342	rs587776783	NC_000013.11:48373492:G:A
NM_000321.2(RB1):c.1363C>T (p.Arg455Ter)	RB1	R455*	Hereditary cancer-predisposing syndrome|not provided|Retinoblastoma	Pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000126837	13	48953760	13	48379624	126837	132347	rs121913302	NC_000013.11:48379623:C:T
NM_000321.2(RB1):c.1399C>T (p.Arg467Ter)	RB1	R467*	not provided|Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Dec 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000092839	13	48954198	13	48380062	92839	98746	rs398123331	NC_000013.11:48380061:C:T
NM_000321.3(RB1):c.1654C>T	RB1	R552*	Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000126840	13	48955538	13	48381402	126840	132350	rs121913303	NC_000013.11:48381401:C:T
NM_000321.2(RB1):c.1666C>T (p.Arg556Ter)	RB1	R556*	Neoplasm|Retinoblastoma|Hereditary cancer-predisposing syndrome|Retinoblastoma, trilateral	Pathogenic(Last reviewed: Feb 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013090	13	48955550	13	48381414	13090	28129	rs121913304	NC_000013.11:48381413:C:T
NM_000321.2(RB1):c.1735C>T (p.Arg579Ter)	RB1	R579*	not provided|Hereditary cancer-predisposing syndrome|Retinoblastoma	Pathogenic(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000126785	13	49027168	13	48453032	126785	132295	rs121913305	NC_000013.11:48453031:C:T
NM_000321.3(RB1):c.1981C>T	RB1		Vulvar adenocarcinoma of mammary gland type|not provided|Hereditary cancer-predisposing syndrome|Retinoblastoma|Small cell lung carcinoma|Osteosarcoma|Urinary bladder cancer|Retinoblastoma	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013087	13	49033844	13	48459708	13087	28126	rs137853294	NC_000013.11:48459707:C:T
NM_000321.3(RB1):c.2325+1G>A	RB1		Hereditary cancer-predisposing syndrome|Retinoblastoma|not provided	Pathogenic(Last reviewed: May 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428709	13	49039248	13	48465112	428709	420575	rs1131690882	NC_000013.11:48465111:G:A
NM_000321.3(RB1):c.2359C>T	RB1	R787*	Hereditary cancer-predisposing syndrome|not provided|Retinoblastoma	Pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000013073	13	49039374	13	48465238	13073	28112	rs137853293	NC_000013.11:48465237:C:T
NM_000321.2(RB1):c.2520+1G>A	RB1		Retinoblastoma	Pathogenic(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000126805	13	49047527	13	48473391	126805	132315	rs587778850	NC_000013.11:48473390:G:A
NM_000257.4(MYH7):c.1357C>T (p.Arg453Cys)	MYH7	R453C	Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|not provided|Primary dilated cardiomyopathy|Primary familial hypertrophic cardiomyopathy	Pathogenic(Last reviewed: Dec 15, 2016)	reviewed by expert panel	VCV000014089	14	23898214	14	23429005	14089	29128	rs121913625	NC_000014.9:23429004:G:A
NM_177438.2(DICER1):c.2062C>T (p.Arg688Ter)	DICER1	R688*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Apr 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254303	14	95578563	14	95112226	254303	248861	rs886037684	NC_000014.9:95112225:G:A
NM_030621.4(DICER1):c.2026C>T (p.Arg676Ter)	DICER1	R676*	not provided|Rhabdomyosarcoma (disease)|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000242054	14	95579443	14	95113106	242054	241976	rs878855246	NC_000014.9:95113105:G:A
NM_030621.4(DICER1):c.1966C>T (p.Arg656Ter)	DICER1	R656*	DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000254301	14	95579503	14	95113166	254301	248863	rs754081635	NC_000014.9:95113165:G:A
NM_030621.4(DICER1):c.1630C>T (p.Arg544Ter)	DICER1	R544*	not provided|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome|Pleuropulmonary blastoma	Pathogenic(Last reviewed: Mar 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004472	14	95582912	14	95116575	4472	19511	rs137852979	NC_000014.9:95116574:G:A
NM_030621.4(DICER1):c.1174C>T (p.Arg392Ter)	DICER1	R392*	Rhabdomyosarcoma (disease)|not provided|Hereditary cancer-predisposing syndrome|DICER1-related pleuropulmonary blastoma cancer predisposition syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jun 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000429141	14	95590735	14	95124398	429141	421138	rs1131691211	NC_000014.9:95124397:G:A
NM_002755.4(MAP2K1):c.199G>A (p.Asp67Asn)	MAP2K1	D67N	MAP2K1-related RASopathy|Cardiofaciocutaneous syndrome 3|not provided|Melanoma|Rasopathy|Cardio-facio-cutaneous syndrome|Noonan syndrome|Cardio-facio-cutaneous syndrome|Autism spectrum disorder|Non-small cell lung cancer	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000040781	15	66727483	15	66435145	40781	49251	rs727504317	NC_000015.10:66435144:G:A
NM_002755.3(MAP2K1):c.370C>T (p.Pro124Ser)	MAP2K1	P124S	Melanoma|Neoplasm of the large intestine|Rasopathy|not provided|Malignant neoplasm of body of uterus|Cardiofaciocutaneous syndrome 3|Malignant melanoma of skin|Noonan syndrome|Transitional cell carcinoma of the bladder	Pathogenic(Last reviewed: Jul 2, 2020)	reviewed by expert panel	VCV000375981	15	66729162	15	66436824	375981	362860	rs1057519732	NC_000015.10:66436823:C:T
NM_002755.4(MAP2K1):c.371C>T (p.Pro124Leu)	MAP2K1	P124L	Neoplasm of the large intestine|Malignant neoplasm of body of uterus|Cardio-facio-cutaneous syndrome|not provided|Malignant melanoma of skin|Transitional cell carcinoma of the bladder|Melanoma|Cardiofaciocutaneous syndrome 3	Pathogenic/Likely pathogenic(Last reviewed: Oct 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000040744	15	66729163	15	66436825	40744	49214	rs397516792	NC_000015.10:66436824:C:T
NM_001289910.1(IDH2):c.263G>A (p.Arg88Gln)	IDH2	R140Q, R88Q, R10Q	Myelodysplastic syndrome|Multiple myeloma|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|D-2-hydroxyglutaric aciduria 2|not provided|Neoplasm of the large intestine	Pathogenic/Likely pathogenic(Last reviewed: Jul 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000014716	15	90631934	15	90088702	14716	29755	rs121913502	NC_000015.10:90088701:C:T
NM_000548.5(TSC2):c.1832G>A (p.Arg611Gln)	TSC2	R611Q, R411Q, R622Q, R574Q, R562Q	not provided|Focal cortical dysplasia type II|Lymphangiomyomatosis|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Hereditary cancer-predisposing syndrome|Tuberous sclerosis 2|Lymphangiomyomatosis	Pathogenic(Last reviewed: Sep 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012397	16	2120572	16	2070571	12397	27436	rs28934872	NC_000016.10:2070570:G:A
NM_000546.6(TP53):c.1101-2A>G	TP53		Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000141332	17	7573010	17	7669692	141332	151046	rs587781664	NC_000017.11:7669691:T:C
NM_000546.5(TP53):c.1025G>C (p.Arg342Pro)	TP53	R210P, R303P, R342P, R183P	Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Neoplasm of ovary	Pathogenic/Likely pathogenic(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215996	17	7574002	17	7670684	215996	213385	rs375338359	NC_000017.11:7670683:C:G
NM_000546.5(TP53):c.1024C>T (p.Arg342Ter)	TP53	R210*, R303*, R342*, R183*	not provided|Hereditary cancer-predisposing syndrome|Colonic diverticula|Gallbladder cancer|Li-Fraumeni syndrome|Neoplasm of ovary	Pathogenic(Last reviewed: Feb 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000182970	17	7574003	17	7670685	182970	180988	rs730882029	NC_000017.11:7670684:G:A
NM_000546.5(TP53):c.1009C>T (p.Arg337Cys)	TP53	R205C, R298C, R337C, R178C	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Li-Fraumeni syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142536	17	7574018	17	7670700	142536	152250	rs587782529	NC_000017.11:7670699:G:A
NM_000546.6(TP53):c.993+1G>C	TP53		not provided|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379801	17	7576852	17	7673534	379801	375717	rs11575997	NC_000017.11:7673533:C:G
NM_000546.5(TP53):c.976G>T (p.Glu326Ter)	TP53	E194*, E287*, E326*, E167*	Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Nov 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000231815	17	7576870	17	7673552	231815	236448	rs876659384	NC_000017.11:7673551:C:A
NM_000546.5(TP53):c.920-1G>T	TP53		Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary	Pathogenic(Last reviewed: Jul 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000480765	17	7576927	17	7673609	480765	479996	rs587781702	NC_000017.11:7673608:C:A
NM_000546.5(TP53):c.920-1G>A	TP53		Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141377	17	7576927	17	7673609	141377	151091	rs587781702	NC_000017.11:7673608:C:T
NM_000546.6(TP53):c.920-2A>G	TP53		Li-Fraumeni syndrome|none provided|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000043595	17	7576928	17	7673610	43595	52764	rs397516439	NC_000017.11:7673609:T:C
NM_000546.5(TP53):c.919+2T>G	TP53		Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000428877	17	7577017	17	7673699	428877	420641	rs1131691016	NC_000017.11:7673698:A:C
NM_000546.5(TP53):c.916C>T (p.Arg306Ter)	TP53	R174*, R267*, R306*, R147*	Neoplasm of ovary|not provided|Neoplasm of the large intestine|none provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Lip and oral cavity carcinoma|Head and Neck Neoplasms|Li-Fraumeni syndrome 1	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000142144	17	7577022	17	7673704	142144	151858	rs121913344	NC_000017.11:7673703:G:A
NM_000546.5(TP53):c.892G>T (p.Glu298Ter)	TP53	E166*, E259*, E298*, E139*	not provided|Neoplasm of ovary|Rhabdomyosarcoma (disease)|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000093323	17	7577046	17	7673728	93323	99230	rs201744589	NC_000017.11:7673727:C:A
NM_000546.5(TP53):c.856G>A (p.Glu286Lys)	TP53	E154K, E247K, E286K, E127K	Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|not provided|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Vulvar adenocarcinoma of mammary gland type|Carcinoma of esophagus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|Small cell lung carcinoma|Malignant melanoma of skin|Acute myeloid leukemia|Breast neoplasm|Neoplasm of brain|Lung adenocarcinoma|Neoplasm of the large intestine	Pathogenic(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183752	17	7577082	17	7673764	183752	185345	rs786201059	NC_000017.11:7673763:C:T
NM_000546.5(TP53):c.853G>A (p.Glu285Lys)	TP53	E153K, E246K, E285K, E126K	Poly (ADP-Ribose) polymerase inhibitor response|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000420133	17	7577085	17	7673767	420133	410258	rs112431538	NC_000017.11:7673766:C:T
NM_000546.6(TP53):c.845G>C (p.Arg282Pro)	TP53	R150P, R243P, R282P, R123P	Neoplasm of the large intestine|Breast neoplasm|Squamous cell carcinoma of the head and neck|Renal cell carcinoma, papillary, 1|Squamous cell lung carcinoma|Squamous cell carcinoma of the skin|Glioblastoma|Carcinoma of esophagus|Pancreatic adenocarcinoma|Malignant melanoma of skin|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Non-Hodgkin lymphoma|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Adenocarcinoma of stomach|Li-Fraumeni syndrome|Hepatocellular carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376659	17	7577093	17	7673775	376659	363538	rs730882008	NC_000017.11:7673774:C:G
NM_000546.5(TP53):c.844C>G (p.Arg282Gly)	TP53	R150G, R243G, R282G, R123G	Li-Fraumeni syndrome|Neoplasm of ovary|Malignant melanoma of skin|Renal cell carcinoma, papillary, 1|Breast neoplasm|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Hepatocellular carcinoma|Neoplasm of brain|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Neoplasm of the large intestine|Glioblastoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Squamous cell lung carcinoma|Lung adenocarcinoma|Non-Hodgkin lymphoma|Pancreatic adenocarcinoma	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000140821	17	7577094	17	7673776	140821	150535	rs28934574	NC_000017.11:7673775:G:C
NM_000546.6(TP53):c.844C>T (p.Arg282Trp)	TP53	R282W, R150W, R243W, R123W	Hereditary cancer-predisposing syndrome|Malignant melanoma of skin|Hepatocellular carcinoma|Renal cell carcinoma, papillary, 1|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Non-Hodgkin lymphoma|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|not provided|Pleomorphic xanthoastrocytoma|Astrocytoma, anaplastic|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Neoplasm of the large intestine|Glioblastoma|Li-Fraumeni-like syndrome|Neoplasm of ovary|Adenocarcinoma of stomach|Colorectal cancer|Carcinoma of esophagus	Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012364	17	7577094	17	7673776	12364	27403	rs28934574	NC_000017.11:7673775:G:A
NM_000546.5(TP53):c.842A>T (p.Asp281Val)	TP53	D149V, D242V, D281V, D122V	Renal cell carcinoma, papillary, 1|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Multiple myeloma|Neuroblastoma|Malignant melanoma of skin|Hepatocellular carcinoma|not provided|Squamous cell carcinoma of the head and neck|Chronic lymphocytic leukemia|Hereditary cancer-predisposing syndrome|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Adenocarcinoma of stomach|Lung adenocarcinoma|Li-Fraumeni syndrome|Breast neoplasm|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder	Pathogenic/Likely pathogenic(Last reviewed: Jun 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000182968	17	7577096	17	7673778	182968	180995	rs587781525	NC_000017.11:7673777:T:A
NM_000546.5(TP53):c.842A>G (p.Asp281Gly)	TP53	D149G, D242G, D281G, D122G	Glioblastoma|Transitional cell carcinoma of the bladder|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Multiple myeloma|Neuroblastoma|Malignant melanoma of skin|Renal cell carcinoma, papillary, 1|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Squamous cell carcinoma of the skin|Squamous cell lung carcinoma|Lung adenocarcinoma|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|Breast neoplasm|Chronic lymphocytic leukemia|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Nov 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000141141	17	7577096	17	7673778	141141	150855	rs587781525	NC_000017.11:7673777:T:C
NM_000546.5(TP53):c.836G>A (p.Gly279Glu)	TP53	G147E, G240E, G279E, G120E	Hereditary cancer-predisposing syndrome|not provided|Neoplasm of ovary|Squamous cell carcinoma of the head and neck|not specified	Pathogenic/Likely pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419454	17	7577102	17	7673784	419454	410259	rs1064793881	NC_000017.11:7673783:C:T
NM_000546.5(TP53):c.824G>A (p.Cys275Tyr)	TP53	C143Y, C236Y, C275Y, C116Y	Glioblastoma|Multiple myeloma|Hepatocellular carcinoma|Renal cell carcinoma, papillary, 1|Squamous cell carcinoma of the head and neck|Chronic lymphocytic leukemia|Breast neoplasm|Transitional cell carcinoma of the bladder|not provided|Neoplasm of the large intestine|Lung adenocarcinoma|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Ovarian Serous Cystadenocarcinoma|Adrenocortical carcinoma|Carcinoma of esophagus|Pancreatic adenocarcinoma|Malignant melanoma of skin|Neoplasm of ovary	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000215997	17	7577114	17	7673796	215997	213392	rs863224451	NC_000017.11:7673795:C:T
NM_000546.5(TP53):c.818G>T (p.Arg273Leu)	TP53	R141L, R234L, R273L, R114L	Transitional cell carcinoma of the bladder|Brainstem glioma|Small cell lung carcinoma|not provided|Li-Fraumeni syndrome|Metastatic pancreatic neuroendocrine tumours|Multiple myeloma|Glioblastoma|Malignant melanoma of skin|Neoplasm of ovary|Carcinoma of esophagus|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Chronic lymphocytic leukemia|Medulloblastoma|Lung adenocarcinoma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of the large intestine|Acute myeloid leukemia|Neoplasm of brain	Pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376655	17	7577120	17	7673802	376655	363534	rs28934576	NC_000017.11:7673801:C:A
NM_000546.5(TP53):c.818G>C (p.Arg273Pro)	TP53	R141P, R234P, R273P, R114P	Small cell lung carcinoma|Multiple myeloma|Li-Fraumeni syndrome|Medulloblastoma|Neoplasm of ovary|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Lung adenocarcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Brainstem glioma|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adrenocortical carcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Hepatocellular carcinoma|Acute myeloid leukemia	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231060	17	7577120	17	7673802	231060	236461	rs28934576	NC_000017.11:7673801:C:G
NM_000546.6(TP53):c.818G>A (p.Arg273His)	TP53	R273H, R141H, R234H, R114H	Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Adrenocortical carcinoma|Colorectal cancer|Multiple myeloma|not provided|Uterine Carcinosarcoma|Neoplasm|Neoplasm of the large intestine|Glioblastoma|Malignant tumor of breast|Chronic lymphocytic leukemia|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Brainstem glioma|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Adrenocortical carcinoma, hereditary|Carcinoma of colon|Choroid plexus papilloma|Familial cancer of breast|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Carcinoma of pancreas|Nasopharyngeal carcinoma|Osteosarcoma|Glioma susceptibility 1|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome 1|Neoplasm of brain|Thyroid gland undifferentiated (anaplastic) carcinoma|Lung adenocarcinoma|Breast neoplasm|Multiple myeloma|not specified|Neoplasm of ovary|Malignant melanoma of skin|Hepatocellular carcinoma|Acute myeloid leukemia|Small cell lung carcinoma|Familial cancer of breast|Li-Fraumeni syndrome|Medulloblastoma	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000012366	17	7577120	17	7673802	12366	27405	rs28934576	NC_000017.11:7673801:C:T
NM_000546.5(TP53):c.817C>G (p.Arg273Gly)	TP53	R141G, R234G, R273G, R114G	Neoplasm of ovary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000634682	17	7577121	17	7673803	634682	622586	rs121913343	NC_000017.11:7673802:G:C
NM_000546.5(TP53):c.817C>A (p.Arg273Ser)	TP53	R141S, R234S, R273S, R114S	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Chronic lymphocytic leukemia|Uterine Carcinosarcoma|Neoplasm of the large intestine|Hepatocellular carcinoma|Small cell lung carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Squamous cell lung carcinoma|Acute myeloid leukemia|Li-Fraumeni syndrome|Glioblastoma|Carcinoma of esophagus|Multiple myeloma|Breast neoplasm|Adrenocortical carcinoma|Medulloblastoma|Pancreatic adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376656	17	7577121	17	7673803	376656	363535	rs121913343	NC_000017.11:7673802:G:T
NM_000546.6(TP53):c.817C>T (p.Arg273Cys)	TP53	R141C, R234C, R273C, R114C	Breast neoplasm|Neoplasm|Acute myeloid leukemia|Hepatocellular carcinoma|not provided|Li-Fraumeni syndrome|Malignant tumor of prostate|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043594	17	7577121	17	7673803	43594	52763	rs121913343	NC_000017.11:7673802:G:A
NM_000546.5(TP53):c.814G>A (p.Val272Met)	TP53	V140M, V233M, V272M, V113M	Multiple myeloma|Neoplasm of ovary|Renal cell carcinoma, papillary, 1|Lung adenocarcinoma|Li-Fraumeni syndrome|Medulloblastoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the skin|Hereditary cancer-predisposing syndrome|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Breast neoplasm	Pathogenic(Last reviewed: Apr 20, 2021)	reviewed by expert panel	VCV000185814	17	7577124	17	7673806	185814	185350	rs121912657	NC_000017.11:7673805:C:T
NM_000546.5(TP53):c.809T>C (p.Phe270Ser)	TP53	F138S, F231S, F270S, F111S	Adenocarcinoma of stomach|Carcinoma of esophagus|Ovarian Serous Cystadenocarcinoma|Breast neoplasm|Neoplasm of brain|not provided|Squamous cell lung carcinoma|Lung adenocarcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin	Pathogenic/Likely pathogenic(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000376594	17	7577129	17	7673811	376594	363473	rs1057519986	NC_000017.11:7673810:A:G
NM_000546.5(TP53):c.799C>T (p.Arg267Trp)	TP53	R135W, R228W, R267W, R108W	Familial cancer of breast|Osteosarcoma|Carcinoma of colon|Choroid plexus papilloma|Adrenocortical carcinoma, hereditary|Basal cell carcinoma, susceptibility to, 7|Hepatocellular carcinoma|Carcinoma of pancreas|Li-Fraumeni syndrome 1|Glioma susceptibility 1|Nasopharyngeal carcinoma|not provided|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Lip and oral cavity carcinoma	Pathogenic/Likely pathogenic(Last reviewed: Feb 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000141764	17	7577139	17	7673821	141764	151478	rs55832599	NC_000017.11:7673820:G:A
NM_000546.6(TP53):c.797G>A (p.Gly266Glu)	TP53	G134E, G227E, G266E, G107E	Breast neoplasm|Neoplasm of brain|Neoplasm of the large intestine|Glioblastoma|Chronic lymphocytic leukemia|Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Pancreatic adenocarcinoma|not provided|Small cell lung carcinoma|Li-Fraumeni syndrome|Carcinoma of esophagus|Hereditary cancer-predisposing syndrome|Malignant melanoma of skin|Neoplasm of ovary|Hepatocellular carcinoma|Squamous cell lung carcinoma|Lung adenocarcinoma|Malignant tumor of prostate|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000161516	17	7577141	17	7673823	161516	171614	rs193920774	NC_000017.11:7673822:C:T
NM_000546.6(TP53):c.783-1G>A	TP53		Hereditary cancer-predisposing syndrome|not provided|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000458565	17	7577156	17	7673838	458565	467511	rs1555525367	NC_000017.11:7673837:C:T
NM_000546.5(TP53):c.772G>T (p.Glu258Ter)	TP53	E219*, E258*, E126*, E99*	Hereditary cancer-predisposing syndrome|Neoplasm of ovary	Pathogenic(Last reviewed: Aug 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000486557	17	7577509	17	7674191	486557	480022	rs121912652	NC_000017.11:7674190:C:A
NM_000546.5(TP53):c.772G>A (p.Glu258Lys)	TP53	E258K, E126K, E219K, E99K	Neoplasm of ovary|not specified|not provided|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012348	17	7577509	17	7674191	12348	27387	rs121912652	NC_000017.11:7674190:C:T
NM_000546.5(TP53):c.751A>C (p.Ile251Leu)	TP53	I119L, I212L, I251L, I92L	Hereditary cancer-predisposing syndrome|not provided|Neoplasm of ovary	Pathogenic/Likely pathogenic(Last reviewed: Jun 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000182937	17	7577530	17	7674212	182937	180998	rs730882007	NC_000017.11:7674211:T:G
NM_000546.5(TP53):c.743G>T (p.Arg248Leu)	TP53	R116L, R209L, R248L, R89L	Small cell lung carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Medulloblastoma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Multiple myeloma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Lung adenocarcinoma|Neoplasm of brain|Brainstem glioma|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000230253	17	7577538	17	7674220	230253	236469	rs11540652	NC_000017.11:7674219:C:A
NM_000546.6(TP53):c.743G>A (p.Arg248Gln)	TP53	R248Q, R116Q, R209Q, R89Q	Malignant Colorectal Neoplasm|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Uterine Carcinosarcoma|Neoplasm|Lymphoma|Lip and oral cavity carcinoma|Neoplasm of the large intestine|Glioblastoma|Chronic lymphocytic leukemia|Ductal carcinoma in situ|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Sarcoma|Squamous cell carcinoma of the head and neck|Breast carcinoma|Adrenocortical carcinoma, hereditary|Carcinoma of colon|Choroid plexus papilloma|Familial cancer of breast|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Carcinoma of pancreas|Nasopharyngeal carcinoma|Osteosarcoma|Glioma susceptibility 1|Li-Fraumeni syndrome 1|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome 1|Neoplasm of brain|Myelodysplastic syndrome|Lung adenocarcinoma|Breast neoplasm|Multiple myeloma|Neoplasm of ovary|Malignant melanoma of skin|Hepatocellular carcinoma|not provided|Acute myeloid leukemia|Familial cancer of breast|Small cell lung carcinoma|Li-Fraumeni syndrome|Medulloblastoma	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000012356	17	7577538	17	7674220	12356	27395	rs11540652	NC_000017.11:7674219:C:T
NM_000546.6(TP53):c.742C>T (p.Arg248Trp)	TP53	R248W, R116W, R209W, R89W	not provided|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Gallbladder cancer|Pancytopenia|Short stature|Acute myeloid leukemia|Webbed neck|Abnormality of the tongue|Cognitive impairment|Pectus excavatum|Uterine Carcinosarcoma|Neoplasm|Lip and oral cavity carcinoma|Neoplasm of the large intestine|Glioblastoma|Chronic lymphocytic leukemia|Carcinoma of esophagus|Brainstem glioma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome 1|Neoplasm of brain|Myelodysplastic syndrome|Choroid plexus carcinoma|Lung adenocarcinoma|Breast neoplasm|Multiple myeloma|Neoplasm of ovary|Malignant melanoma of skin|Small cell lung carcinoma|Hepatocellular carcinoma|Acute myeloid leukemia|Li-Fraumeni syndrome|Medulloblastoma	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000012347	17	7577539	17	7674221	12347	27386	rs121912651	NC_000017.11:7674220:G:A
NM_000546.5(TP53):c.736A>G (p.Met246Val)	TP53	M114V, M207V, M246V, M87V	not provided|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100815	17	7577545	17	7674227	100815	106675	rs483352695	NC_000017.11:7674226:T:C
NM_000546.5(TP53):c.734G>T (p.Gly245Val)	TP53	G113V, G206V, G245V, G86V	Squamous cell lung carcinoma|Uterine Carcinosarcoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Breast neoplasm|not provided|Li-Fraumeni syndrome|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Glioblastoma|Hepatocellular carcinoma|Carcinoma of esophagus|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|Brainstem glioma	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376603	17	7577547	17	7674229	376603	363482	rs121912656	NC_000017.11:7674228:C:A
NM_000546.5(TP53):c.734G>A (p.Gly245Asp)	TP53	G245D, G113D, G206D, G86D	Lung adenocarcinoma|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|Brainstem glioma|Transitional cell carcinoma of the bladder|Neoplasm of ovary|not provided|Carcinoma of esophagus|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of brain|Uterine Carcinosarcoma|Li-Fraumeni syndrome|Glioblastoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome 1|Neoplasm of the large intestine	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012355	17	7577547	17	7674229	12355	27394	rs121912656	NC_000017.11:7674228:C:T
NM_000546.6(TP53):c.733G>A (p.Gly245Ser)	TP53	G245S, G113S, G206S, G86S	Atypical teratoid/rhabdoid tumor|Astrocytoma, anaplastic|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|not provided|Familial ovarian cancer|Uterine Carcinosarcoma|Neoplasm|Neoplasm of the large intestine|Glioblastoma|Li-Fraumeni-like syndrome|Colorectal cancer|Adenocarcinoma|Carcinoma of esophagus|Brainstem glioma|Transitional cell carcinoma of the bladder|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|Squamous cell lung carcinoma|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Breast neoplasm|Neoplasm of brain|Neoplasm of ovary|Hepatocellular carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000012365	17	7577548	17	7674230	12365	27404	rs28934575	NC_000017.11:7674229:C:T
NM_000546.5(TP53):c.733G>T (p.Gly245Cys)	TP53	G245C, G113C, G206C, G86C	Uterine Carcinosarcoma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|not provided|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Hepatocellular carcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Breast and/or ovarian cancer|Pancreatic adenocarcinoma|Breast neoplasm|Glioblastoma|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012349	17	7577548	17	7674230	12349	27388	rs28934575	NC_000017.11:7674229:C:A
NM_000546.5(TP53):c.731G>A (p.Gly244Asp)	TP53	G112D, G205D, G244D, G85D	Li-Fraumeni syndrome|Neoplasm of ovary|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of the large intestine|Squamous cell lung carcinoma|Glioblastoma|Carcinoma of esophagus|not provided|Squamous cell carcinoma of the head and neck|Neoplasm of brain|Lung adenocarcinoma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Small cell lung carcinoma|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach	Pathogenic/Likely pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372785	17	7577550	17	7674232	372785	360335	rs985033810	NC_000017.11:7674231:C:T
NM_000546.5(TP53):c.730G>A (p.Gly244Ser)	TP53	G112S, G205S, G244S, G85S	Hepatocellular carcinoma|Neoplasm of the large intestine|Squamous cell lung carcinoma|Glioblastoma|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Lung adenocarcinoma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Small cell lung carcinoma|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376600	17	7577551	17	7674233	376600	363479	rs1057519989	NC_000017.11:7674232:C:T
NM_000546.5(TP53):c.725G>A (p.Cys242Tyr)	TP53	C242Y, C110Y, C203Y, C83Y	Uterine Carcinosarcoma|Squamous cell lung carcinoma|Chronic lymphocytic leukemia|Li-Fraumeni-like syndrome|Adenocarcinoma of stomach|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Hepatocellular carcinoma|Squamous cell carcinoma of the head and neck|Carcinoma of esophagus|Breast neoplasm|Glioblastoma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012354	17	7577556	17	7674238	12354	27393	rs121912655	NC_000017.11:7674237:C:T
NM_000546.5(TP53):c.713G>C (p.Cys238Ser)	TP53	C106S, C199S, C238S, C79S	Pancreatic adenocarcinoma|Li-Fraumeni syndrome 1|Lung adenocarcinoma|Carcinoma of esophagus|Glioblastoma|Multiple myeloma|not provided|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|Neoplasm of uterine cervix|Uterine Carcinosarcoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Breast neoplasm|Hepatocellular carcinoma|Neoplasm of the large intestine|Chronic lymphocytic leukemia|Neoplasm of brain	Pathogenic/Likely pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376575	17	7577568	17	7674250	376575	363454	rs730882005	NC_000017.11:7674249:C:G
NM_000546.5(TP53):c.713G>A (p.Cys238Tyr)	TP53	C106Y, C199Y, C238Y, C79Y	Chronic lymphocytic leukemia|Pancreatic adenocarcinoma|Multiple myeloma|Neoplasm of brain|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|not provided|Lung adenocarcinoma|Transitional cell carcinoma of the bladder|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Gallbladder cancer|Neoplasm of the large intestine|Glioblastoma|Hepatocellular carcinoma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Neoplasm of uterine cervix|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Carcinoma of esophagus|Breast neoplasm	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000182935	17	7577568	17	7674250	182935	181000	rs730882005	NC_000017.11:7674249:C:T
NM_000546.5(TP53):c.712T>C (p.Cys238Arg)	TP53	C106R, C199R, C238R, C79R	Chronic lymphocytic leukemia|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Carcinoma of esophagus|Transitional cell carcinoma of the bladder|Adenocarcinoma of stomach|Glioblastoma|Breast neoplasm|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Multiple myeloma|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Uterine Carcinosarcoma|Neoplasm of uterine cervix|Neoplasm of the large intestine|Hepatocellular carcinoma|Lung adenocarcinoma	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376576	17	7577569	17	7674251	376576	363455	rs1057519981	NC_000017.11:7674250:A:G
NM_000546.5(TP53):c.711G>A (p.Met237Ile)	TP53	M105I, M198I, M237I, M78I	Li-Fraumeni syndrome 1|Brainstem glioma|Neoplasm of the large intestine|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Breast neoplasm|Neoplasm of brain|Squamous cell lung carcinoma|Lung adenocarcinoma|Carcinoma of esophagus|Breast and/or ovarian cancer|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|not specified|Neoplasm of ovary	Pathogenic(Last reviewed: Apr 20, 2021)	reviewed by expert panel	VCV000142714	17	7577570	17	7674252	142714	152428	rs587782664	NC_000017.11:7674251:C:T
NM_000546.5(TP53):c.701A>G (p.Tyr234Cys)	TP53	Y102C, Y195C, Y234C, Y75C	Small cell lung carcinoma|Adrenocortical carcinoma|Hepatocellular carcinoma|Li-Fraumeni syndrome|not provided|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|Squamous cell lung carcinoma|Adenocarcinoma of prostate|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Glioblastoma|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of ovary|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000127820	17	7577580	17	7674262	127820	133277	rs587780073	NC_000017.11:7674261:T:C
NM_000546.5(TP53):c.700T>C (p.Tyr234His)	TP53	Y102H, Y195H, Y234H, Y75H	Squamous cell lung carcinoma|Pancreatic adenocarcinoma|Breast neoplasm|Neoplasm of ovary|Hepatocellular carcinoma|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Adrenocortical carcinoma|Neoplasm of the large intestine|Glioblastoma|Carcinoma of esophagus|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Transitional cell carcinoma of the bladder|Small cell lung carcinoma	Pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376691	17	7577581	17	7674263	376691	363570	rs864622237	NC_000017.11:7674262:A:G
NM_000546.5(TP53):c.672+1G>T	TP53		not provided|Neoplasm of ovary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000630765	17	7578176	17	7674858	630765	619765	rs863224499	NC_000017.11:7674857:C:A
NM_000546.6(TP53):c.659A>G (p.Tyr220Cys)	TP53	Y181C, Y220C, Y88C, Y61C	Neoplasm of the large intestine|not provided|Renal cell carcinoma, papillary, 1|Lung adenocarcinoma|Malignant melanoma of skin|Neoplasm of ovary|Glioblastoma|Pancreatic adenocarcinoma|Chronic lymphocytic leukemia|Small cell lung carcinoma|Breast neoplasm|Neoplasm of brain|Li-Fraumeni syndrome|Adenocarcinoma of prostate|Papillary renal cell carcinoma, sporadic|Uterine Carcinosarcoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Acute myeloid leukemia|Squamous cell lung carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Hepatocellular carcinoma	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000127819	17	7578190	17	7674872	127819	133276	rs121912666	NC_000017.11:7674871:T:C
NM_000546.5(TP53):c.638G>C (p.Arg213Pro)	TP53	R174P, R213P, R81P, R54P	Neoplasm of the large intestine|Malignant melanoma of skin|Glioblastoma|Carcinoma of esophagus|Renal cell carcinoma, papillary, 1|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of brain|Squamous cell lung carcinoma|Lung adenocarcinoma|Uterine Carcinosarcoma|Adenocarcinoma of prostate|Adenoid cystic carcinoma|Ovarian Serous Cystadenocarcinoma|Nasopharyngeal Neoplasms|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Adrenocortical carcinoma|Hepatocellular carcinoma|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|not specified|Squamous cell carcinoma of the head and neck	Pathogenic/Likely pathogenic(Last reviewed: Apr 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000231214	17	7578211	17	7674893	231214	236477	rs587778720	NC_000017.11:7674892:C:G
NM_000546.6(TP53):c.638G>A (p.Arg213Gln)	TP53	R174Q, R213Q, R81Q, R54Q	Uterine Carcinosarcoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|not provided|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of brain|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the skin|Poly (ADP-Ribose) polymerase inhibitor response|Squamous cell lung carcinoma|Lung adenocarcinoma|Renal cell carcinoma, papillary, 1|Hepatocellular carcinoma|Lip and oral cavity carcinoma|Glioblastoma|Carcinoma of esophagus|not specified|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Adenoid cystic carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Nasopharyngeal Neoplasms|Adrenocortical carcinoma|Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Li-Fraumeni syndrome 1	Pathogenic(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000135359	17	7578211	17	7674893	135359	139098	rs587778720	NC_000017.11:7674892:C:T
NM_000546.6(TP53):c.637C>T (p.Arg213Ter)	TP53	R174*, R213*, R81*, R54*	Familial cancer of breast|Colorectal cancer|not provided|not specified|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043590	17	7578212	17	7674894	43590	52759	rs397516436	NC_000017.11:7674893:G:A
NM_000546.6(TP53):c.586C>T (p.Arg196Ter)	TP53	R157*, R196*, R64*, R37*	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided|Neoplasm of ovary|not specified	Pathogenic(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000043589	17	7578263	17	7674945	43589	52758	rs397516435	NC_000017.11:7674944:G:A
NM_000546.5(TP53):c.584T>C (p.Ile195Thr)	TP53	I156T, I195T, I63T, I36T	Lung adenocarcinoma|Pancreatic adenocarcinoma|Multiple myeloma|Hepatocellular carcinoma|Neoplasm of the large intestine|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|not provided|Breast neoplasm|Chronic lymphocytic leukemia|Neoplasm of ovary|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Breast and/or ovarian cancer|Neoplasm of brain|Li-Fraumeni syndrome|Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Acute myeloid leukemia	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000216077	17	7578265	17	7674947	216077	213398	rs760043106	NC_000017.11:7674946:A:G
NM_000546.5(TP53):c.578A>C (p.His193Pro)	TP53	H154P, H193P, H61P, H34P	Neoplasm of the large intestine|Hepatocellular carcinoma|Small cell lung carcinoma|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Chronic lymphocytic leukemia|Neoplasm of brain|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Carcinoma of esophagus|Hereditary cancer-predisposing syndrome|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Breast neoplasm|Acute myeloid leukemia|Pancreatic adenocarcinoma	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000376612	17	7578271	17	7674953	376612	363491	rs786201838	NC_000017.11:7674952:T:G
NM_000546.5(TP53):c.578A>G (p.His193Arg)	TP53	H154R, H193R, H61R, H34R	Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Neoplasm of ovary|Brainstem glioma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Li-Fraumeni syndrome|Chronic lymphocytic leukemia|Carcinoma of esophagus|Hereditary cancer-predisposing syndrome|Papillary renal cell carcinoma, sporadic|Uterine Carcinosarcoma|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|Acute myeloid leukemia|Small cell lung carcinoma|Squamous cell lung carcinoma|Breast neoplasm|Neoplasm of brain|Lung adenocarcinoma|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000184979	17	7578271	17	7674953	184979	185367	rs786201838	NC_000017.11:7674952:T:C
NM_000546.6(TP53):c.542G>A (p.Arg181His)	TP53	R142H, R181H, R49H, R22H	Hereditary cancer-predisposing syndrome|Carcinoma of pancreas|Familial cancer of breast|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|not provided|Squamous cell carcinoma of the head and neck	Pathogenic/Likely pathogenic(Last reviewed: Jul 27, 2021)	criteria provided, multiple submitters, no conflicts	VCV000142320	17	7578388	17	7675070	142320	152034	rs397514495	NC_000017.11:7675069:C:T
NM_000546.6(TP53):c.537T>A	TP53	H140Q, H47Q, H179Q, H20Q	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000406578	17	7578393	17	7675075	406578	402563	rs876660821	NC_000017.11:7675074:A:T
NM_000546.5(TP53):c.537T>G (p.His179Gln)	TP53	H140Q, H179Q, H47Q, H20Q	Hepatocellular carcinoma|Small cell lung carcinoma|Squamous cell carcinoma of the skin|Lung adenocarcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Carcinoma of gallbladder|Uterine Carcinosarcoma|Neoplasm of the large intestine|Squamous cell carcinoma of the head and neck|Acute myeloid leukemia|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Squamous cell lung carcinoma|Glioblastoma|Carcinoma of esophagus|Breast neoplasm|Li-Fraumeni syndrome|Pancreatic adenocarcinoma	Pathogenic(Last reviewed: Nov 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376607	17	7578393	17	7675075	376607	363486	rs876660821	NC_000017.11:7675074:A:C
NM_000546.5(TP53):c.535C>T (p.His179Tyr)	TP53	H140Y, H179Y, H47Y, H20Y	Squamous cell lung carcinoma|Lung adenocarcinoma|Li-Fraumeni syndrome|Breast neoplasm|Neoplasm of brain|not provided|Uterine Carcinosarcoma|Carcinoma of gallbladder|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Carcinoma of esophagus|Li-Fraumeni syndrome 1|Neoplasm of ovary|Neoplasm of the large intestine|Hepatocellular carcinoma|Glioblastoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the skin|Malignant melanoma of skin|Acute myeloid leukemia|Small cell lung carcinoma|Squamous cell carcinoma of the head and neck	Pathogenic/Likely pathogenic(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000127815	17	7578395	17	7675077	127815	133272	rs587780070	NC_000017.11:7675076:G:A
NM_000546.5(TP53):c.527G>A (p.Cys176Tyr)	TP53	C137Y, C176Y, C44Y, C17Y	Renal cell carcinoma, papillary, 1|Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Hereditary cancer-predisposing syndrome|Hepatocellular carcinoma|Li-Fraumeni syndrome|not provided|Familial ovarian cancer|Carcinoma of esophagus|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|Acute myeloid leukemia|Squamous cell lung carcinoma|Breast neoplasm|Neoplasm of brain|Lung adenocarcinoma|Squamous cell carcinoma of the head and neck	Pathogenic/Likely pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000186451	17	7578403	17	7675085	186451	185371	rs786202962	NC_000017.11:7675084:C:T
NM_000546.6(TP53):c.524G>A (p.Arg175His)	TP53	R175H, R136H, R43H, R16H	Li-Fraumeni syndrome 1|Osteosarcoma|Glioma susceptibility 1|Hepatocellular carcinoma|Carcinoma of colon|Familial cancer of breast|Choroid plexus papilloma|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Basal cell carcinoma, susceptibility to, 7|Adrenocortical carcinoma, hereditary|Nasopharyngeal carcinoma|Hereditary cancer-predisposing syndrome|Breast neoplasm|not provided|Colorectal cancer|Lip and oral cavity carcinoma|Neoplasm|Li-Fraumeni syndrome|Neoplasm of ovary|Malignant tumor of esophagus|Squamous cell carcinoma of the head and neck|Familial cancer of breast	Pathogenic(Last reviewed: Jan 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000012374	17	7578406	17	7675088	12374	27413	rs28934578	NC_000017.11:7675087:C:T
NM_000546.5(TP53):c.523C>G (p.Arg175Gly)	TP53	R136G, R175G, R43G, R16G	Medulloblastoma|Chronic lymphocytic leukemia|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Breast neoplasm|Squamous cell lung carcinoma|Brainstem glioma|Glioblastoma|Carcinoma of esophagus|Neoplasm of ovary|Pancreatic adenocarcinoma|Neoplasm of brain|Uterine Carcinosarcoma|Carcinoma of gallbladder|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Nasopharyngeal Neoplasms|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Adenocarcinoma of stomach|Li-Fraumeni syndrome|Malignant melanoma of skin|Hepatocellular carcinoma|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000376649	17	7578407	17	7675089	376649	363528	rs138729528	NC_000017.11:7675088:G:C
NM_000546.5(TP53):c.518T>C (p.Val173Ala)	TP53	V134A, V173A, V41A, V14A	Malignant melanoma of skin|Neoplasm of the large intestine|Brainstem glioma|Acute myeloid leukemia|Small cell lung carcinoma|Li-Fraumeni syndrome|Neoplasm of brain|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Squamous cell carcinoma of the head and neck|Carcinoma of esophagus|Breast neoplasm|Hepatocellular carcinoma|Adenocarcinoma of stomach|Adrenocortical carcinoma|Lung adenocarcinoma|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000376017	17	7578412	17	7675094	376017	362896	rs1057519747	NC_000017.11:7675093:A:G
NM_000546.5(TP53):c.517G>A (p.Val173Met)	TP53	V134M, V173M, V41M, V14M	Lip and oral cavity carcinoma|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|Lung adenocarcinoma|Adrenocortical carcinoma|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Malignant melanoma of skin|Neoplasm of ovary|Hepatocellular carcinoma|not provided|Carcinoma of esophagus|Li-Fraumeni syndrome|Breast neoplasm|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Brainstem glioma|Neoplasm of brain|Small cell lung carcinoma	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000233951	17	7578413	17	7675095	233951	232035	rs876660754	NC_000017.11:7675094:C:T
NM_000546.5(TP53):c.493C>T (p.Gln165Ter)	TP53	Q126*, Q165*, Q33*, Q6*	Neoplasm of ovary|not provided|Squamous cell carcinoma of the head and neck|Lip and oral cavity carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome	Pathogenic(Last reviewed: Jul 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000182930	17	7578437	17	7675119	182930	181011	rs730882001	NC_000017.11:7675118:G:A
NM_000546.5(TP53):c.488A>G (p.Tyr163Cys)	TP53	Y124C, Y163C, Y31C, Y4C	Lung adenocarcinoma|Carcinoma of esophagus|Neoplasm of the large intestine|Malignant melanoma of skin|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|not provided|Small cell lung carcinoma|Breast neoplasm|Neoplasm of brain|Li-Fraumeni syndrome|Uterine Carcinosarcoma|Ovarian Serous Cystadenocarcinoma|Brainstem glioma|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Hepatocellular carcinoma	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000127814	17	7578442	17	7675124	127814	133271	rs148924904	NC_000017.11:7675123:T:C
NM_000546.6(TP53):c.455C>T (p.Pro152Leu)	TP53	P113L, P152L, P20L	Lip and oral cavity carcinoma|Li-Fraumeni syndrome 1|Familial cancer of breast|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|not provided	Pathogenic(Last reviewed: Aug 28, 2019)	reviewed by expert panel	VCV000142766	17	7578475	17	7675157	142766	152480	rs587782705	NC_000017.11:7675156:G:A
NM_000546.6(TP53):c.451C>T (p.Pro151Ser)	TP53	P151S, P112S, P19S	Adenoid cystic carcinoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Uterine Carcinosarcoma|Neoplasm of the large intestine|not provided|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Lung adenocarcinoma|Breast neoplasm|Neoplasm of brain|Multiple myeloma|Neoplasm of ovary|Malignant melanoma of skin|Breast adenocarcinoma|Hepatocellular carcinoma|Li-Fraumeni syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000012370	17	7578479	17	7675161	12370	27409	rs28934874	NC_000017.11:7675160:G:A
NM_000546.6(TP53):c.438G>A	TP53	W107*, W14*, W146*	Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Neoplasm of ovary	Pathogenic(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000428890	17	7578492	17	7675174	428890	420663	rs1131691026	NC_000017.11:7675173:C:T
NM_000546.5(TP53):c.437G>A (p.Trp146Ter)	TP53	W107*, W14*, W146*	Neoplasm of ovary|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000634785	17	7578493	17	7675175	634785	622628	rs1206165503	NC_000017.11:7675174:C:T
NM_000546.5(TP53):c.422G>A (p.Cys141Tyr)	TP53	C102Y, C141Y, C9Y	Renal cell carcinoma, papillary, 1|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Li-Fraumeni syndrome|Multiple myeloma|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Acute myeloid leukemia|Breast neoplasm|Neoplasm of brain|Lung adenocarcinoma	Pathogenic(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000140801	17	7578508	17	7675190	140801	150515	rs587781288	NC_000017.11:7675189:C:T
NM_000546.5(TP53):c.376-1G>A	TP53		not provided|Lip and oral cavity carcinoma|Li-Fraumeni syndrome|Neoplasm of ovary|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000481003	17	7578555	17	7675237	481003	479357	rs868137297	NC_000017.11:7675236:C:T
NM_000546.5(TP53):c.375+1G>A	TP53		Li-Fraumeni syndrome|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000634702	17	7579311	17	7675993	634702	622670	rs1567555445	NC_000017.11:7675992:C:T
NM_000546.5(TP53):c.374C>G (p.Thr125Arg)	TP53	T125R, T86R	Malignant melanoma of skin|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Hepatocellular carcinoma|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Small cell lung carcinoma|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Ovarian Serous Cystadenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Glioblastoma|Carcinoma of esophagus|Breast neoplasm|Adenocarcinoma of stomach|Adrenocortical carcinoma|Renal cell carcinoma, papillary, 1|Acute myeloid leukemia|Pancreatic adenocarcinoma	Pathogenic/Likely pathogenic(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000376667	17	7579313	17	7675995	376667	363546	rs786201057	NC_000017.11:7675994:G:C
NM_000546.5(TP53):c.329G>T (p.Arg110Leu)	TP53	R110L, R71L	Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000406597	17	7579358	17	7676040	406597	402569	rs11540654	NC_000017.11:7676039:C:A
NM_000546.5(TP53):c.273G>A (p.Trp91Ter)	TP53	W52*, W91*	Neoplasm of ovary|Li-Fraumeni syndrome 1|Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Dec 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000233650	17	7579414	17	7676096	233650	236504	rs876660548	NC_000017.11:7676095:C:T
NM_000546.5(TP53):c.158G>A (p.Trp53Ter)	TP53	W14*, W53*	Li-Fraumeni syndrome|Neoplasm of ovary|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jan 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000230285	17	7579529	17	7676211	230285	236511	rs876658483	NC_000017.11:7676210:C:T
NM_000267.3(NF1):c.4084C>T (p.Arg1362Ter)	NF1	R1362*	Neurofibromatosis, type 1|not provided|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Feb 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000000344	17	29576111	17	31249093	344	15383	rs137854560	NC_000017.11:31249092:C:T
NM_001042492.3(NF1):c.7063-1G>A	NF1		Neurofibromatosis, type 1|not provided	Pathogenic(Last reviewed: May 5, 2021)	criteria provided, multiple submitters, no conflicts	VCV001070419	17	29670026	17	31343008	1070419	1064098		NC_000017.11:31343007:G:A
NM_007294.4(BRCA1):c.5503C>T (p.Arg1835Ter)	BRCA1	R1835*, R1856*, R1788*, R731*	Breast neoplasm|Breast-ovarian cancer, familial 1|Lung cancer|Familial cancer of breast|Neoplasm of ovary|Hereditary breast and ovarian cancer syndrome|Neoplasm of ovary|Familial cancer of breast|Malignant tumor of breast|Breast and/or ovarian cancer|not provided|Hereditary cancer-predisposing syndrome|Breast carcinoma	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000055601	17	41197784	17	43045767	55601	70268	rs41293465	NC_000017.11:43045766:G:A
NM_007294.3(BRCA1):c.5333-1G>T	BRCA1		Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Feb 12, 2019)	criteria provided, multiple submitters, no conflicts	VCV000267600	17	41201212	17	43049195	267600	262921	rs80358126	NC_000017.11:43049194:C:A
NM_007294.3(BRCA1):c.5193+1G>C	BRCA1		not provided|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Feb 11, 2016)	criteria provided, multiple submitters, no conflicts	VCV000055448	17	41215349	17	43063332	55448	70115	rs80358004	NC_000017.11:43063331:C:G
NM_007294.4(BRCA1):c.5173G>T (p.Glu1725Ter)	BRCA1	E1725*, E621*, E1678*, E1746*	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055442	17	41215370	17	43063353	55442	70109	rs80357291	NC_000017.11:43063352:C:A
NM_007294.4(BRCA1):c.4903G>T (p.Glu1635Ter)	BRCA1	E1635*, E1656*, E531*, E1588*	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055311	17	41223028	17	43071011	55311	69978	rs200432771	NC_000017.11:43071010:C:A
NM_007294.4(BRCA1):c.4656C>G (p.Tyr1552Ter)	BRCA1	Y1552*, Y1505*, Y1573*, Y448*	Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055253	17	41226367	17	43074350	55253	69920	rs80357151	NC_000017.11:43074349:G:C
NM_007294.4(BRCA1):c.4487C>A (p.Ser1496Ter)	BRCA1	S1496*, S1449*, S1517*, S392*	Hereditary breast and ovarian cancer syndrome|Neoplasm of ovary|Breast-ovarian cancer, familial 1|Familial cancer of breast	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055215	17	41226536	17	43074519	55215	69882	rs80356953	NC_000017.11:43074518:G:T
NM_007294.4(BRCA1):c.4372C>T (p.Gln1458Ter)	BRCA1	Q1458*, Q1411*, Q1479*, Q354*	not provided|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000055183	17	41228617	17	43076600	55183	69850	rs80356932	NC_000017.11:43076599:G:A
NM_007294.4(BRCA1):c.3607C>T (p.Arg1203Ter)	BRCA1	R1203*, R1156*	not provided|Breast and/or ovarian cancer|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Ovarian cancer|Neoplasm of ovary|Familial cancer of breast|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Apr 22, 2016)	reviewed by expert panel	VCV000017671	17	41243941	17	43091924	17671	32710	rs62625308	NC_000017.11:43091923:G:A
NM_007294.4(BRCA1):c.3352C>T (p.Gln1118Ter)	BRCA1	Q1118*, Q1071*	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|not provided	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037524	17	41244196	17	43092179	37524	46080	rs397507215	NC_000017.11:43092178:G:A
NM_007294.4(BRCA1):c.3026C>A (p.Ser1009Ter)	BRCA1	S1009*, S962*	Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000054756	17	41244522	17	43092505	54756	69423	rs273899696	NC_000017.11:43092504:G:T
NM_007294.4(BRCA1):c.2635G>T (p.Glu879Ter)	BRCA1	E879*, E832*	Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|not provided|Breast and/or ovarian cancer	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000037478	17	41244913	17	43092896	37478	46034	rs80357251	NC_000017.11:43092895:C:A
NM_007294.4(BRCA1):c.1214C>A (p.Ser405Ter)	BRCA1	S405*, S358*	Neoplasm of ovary|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000054164	17	41246334	17	43094317	54164	68831	rs80357481	NC_000017.11:43094316:G:T
NM_007294.4(BRCA1):c.1116G>A (p.Trp372Ter)	BRCA1	W372*, W325*	Hereditary breast and ovarian cancer syndrome|Neoplasm of ovary|not provided|Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Sep 8, 2016)	reviewed by expert panel	VCV000054135	17	41246432	17	43094415	54135	68802	rs80357468	NC_000017.11:43094414:C:T
NM_007294.3(BRCA1):c.213-1G>A	BRCA1		Hereditary breast and ovarian cancer syndrome|Breast neoplasm|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000054472	17	41256974	17	43104957	54472	69139	rs80358146	NC_000017.11:43104956:C:T
NM_007294.4(BRCA1):c.212+1G>T	BRCA1		Malignant tumor of breast|not provided|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054465	17	41258472	17	43106455	54465	69132	rs80358042	NC_000017.11:43106454:C:A
NM_007294.4(BRCA1):c.211A>G (p.Arg71Gly)	BRCA1	R71G, R24G	not provided|Familial cancer of breast|Pancreatic cancer 4|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|not specified|Familial cancer of breast|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000017693	17	41258474	17	43106457	17693	32732	rs80357382	NC_000017.11:43106456:T:C
NM_007294.4(BRCA1):c.181T>G (p.Cys61Gly)	BRCA1	C61G, C14G	not provided|Familial cancer of breast|Pancreatic cancer 4|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial 1|Breast and/or ovarian cancer|none provided|Breast carcinoma|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome|Breast neoplasm|Neoplasm of ovary|Familial cancer of breast|Breast-ovarian cancer, familial 1	Pathogenic(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000017661	17	41258504	17	43106487	17661	32700	rs28897672	NC_000017.11:43106486:A:C
NM_015559.3(SETBP1):c.2608G>A (p.Gly870Ser)	SETBP1	G870S	Schinzel-Giedion syndrome|Chronic myelogenous leukemia, BCR-ABL1 positive	Pathogenic(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000001035	18	42531913	18	44951948	1035	16074	rs267607040	NC_000018.10:44951947:G:A
NM_005359.6(SMAD4):c.1081C>T (p.Arg361Cys)	SMAD4	R361C	Hereditary cancer-predisposing syndrome|Breast neoplasm|JP, JP/HHT, and HHT|not provided|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Adenocarcinoma of stomach|none provided|Squamous cell carcinoma of the head and neck|Pancreatic adenocarcinoma|Juvenile polyposis syndrome|Carcinoma of esophagus|Lung adenocarcinoma|Neoplasm of the large intestine|Neoplasm of uterine cervix|Generalized juvenile polyposis/juvenile polyposis coli	Pathogenic(Last reviewed: Nov 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008543	18	48591918	18	51065548	8543	23582	rs80338963	NC_000018.10:51065547:C:T
NM_005359.6(SMAD4):c.1082G>A (p.Arg361His)	SMAD4	R361H	Lung adenocarcinoma|Carcinoma of esophagus|Neoplasm of the large intestine|Breast neoplasm|Squamous cell carcinoma of the head and neck|Juvenile polyposis syndrome|Neoplasm of uterine cervix|Adenocarcinoma of stomach|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|JP and JP/HHT|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|Carcinoma of pancreas|Generalized juvenile polyposis/juvenile polyposis coli|Myhre syndrome	Pathogenic(Last reviewed: Aug 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024832	18	48591919	18	51065549	24832	36173	rs377767347	NC_000018.10:51065548:G:A
NM_005359.6(SMAD4):c.1333C>T (p.Arg445Ter)	SMAD4	R445*	Generalized juvenile polyposis/juvenile polyposis coli|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome|not provided|Gallbladder cancer|Juvenile polyposis syndrome|Hereditary cancer-predisposing syndrome	Pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000024850	18	48603032	18	51076662	24850	36191	rs377767360	NC_000018.10:51076661:C:T
NM_000455.4(STK11):c.109C>T (p.Gln37Ter)	STK11	Q37*	Neoplasm|Hereditary cancer-predisposing syndrome|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Feb 15, 2017)	criteria provided, multiple submitters, no conflicts	VCV000376334	19	1207021	19	1207022	376334	363213	rs121913324	NC_000019.10:1207021:C:T
NM_000455.4(STK11):c.200T>C (p.Leu67Pro)	STK11	L67P	not provided|Peutz-Jeghers syndrome|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000007445	19	1207112	19	1207113	7445	22484	rs137853077	NC_000019.10:1207112:T:C
NM_000455.4(STK11):c.526G>A (p.Asp176Asn)	STK11	D176N	Peutz-Jeghers syndrome|not provided	Pathogenic(Last reviewed: Oct 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000182907	19	1220433	19	1220434	182907	181057	rs730881979	NC_000019.10:1220433:G:A
NM_000455.4(STK11):c.580G>A (p.Asp194Asn)	STK11	D194N	Peutz-Jeghers syndrome|Neoplasm|not provided|Lung adenocarcinoma|Hereditary cancer-predisposing syndrome	Pathogenic/Likely pathogenic(Last reviewed: Aug 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000188348	19	1220487	19	1220488	188348	186283	rs121913315	NC_000019.10:1220487:G:A
NM_000455.4(STK11):c.910C>T (p.Arg304Trp)	STK11	R304W	Inborn genetic diseases|Hereditary cancer-predisposing syndrome|not provided|Peutz-Jeghers syndrome	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000183802	19	1221995	19	1221996	183802	185520	rs786201090	NC_000019.10:1221995:C:T
NM_030662.3(MAP2K2):c.169T>G (p.Phe57Val)	MAP2K2	F57V	Pancreatic adenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Cardio-facio-cutaneous syndrome|Cardiofaciocutaneous syndrome 4|Squamous cell carcinoma of the head and neck	Pathogenic(Last reviewed: May 9, 2017)	reviewed by expert panel	VCV000008273	19	4117551	19	4117553	8273	23312	rs121434498	NC_000019.10:4117552:A:C
NM_000527.5(LDLR):c.443G>A (p.Cys148Tyr)	LDLR	C148Y, C107Y	Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000251225	19	11216025	19	11105349	251225	245563	rs879254526	NC_000019.10:11105348:G:A
NM_000527.5(LDLR):c.564C>G (p.Tyr188Ter)	LDLR	Y188*, Y147*	Familial hypercholesterolemia|Familial hypercholesterolemia 1	Pathogenic/Likely pathogenic(Last reviewed: Oct 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003727	19	11216146	19	11105470	3727	18766	rs121908034	NC_000019.10:11105469:C:G
NM_000527.5(LDLR):c.682G>A (p.Glu228Lys)	LDLR	E228K, E187K	Homozygous familial hypercholesterolemia|not provided|Aortic dissection|Stroke|Internal carotid artery dissection|Carotid artery occlusion|Carotid artery dissection|Familial hypercholesterolemia 1|Familial hypercholesterolemia	Pathogenic/Likely pathogenic(Last reviewed: Aug 17, 2019)	criteria provided, multiple submitters, no conflicts	VCV000003691	19	11216264	19	11105588	3691	18730		NC_000019.10:11105587:G:A
NM_014225.6(PPP2R1A):c.536C>T (p.Pro179Leu)	PPP2R1A	P179L	not provided|Malignant neoplasm of body of uterus|Uterine Carcinosarcoma|Mental retardation, autosomal dominant 36|PPP2R1A-related neurodevelopmental disorders|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000190313	19	52715971	19	52212718	190313	188142	rs786205228	NC_000019.10:52212717:C:T
NM_001754.4(RUNX1):c.601C>T (p.Arg201Ter)	RUNX1	R201*, R174*	Acute myeloid leukemia|Familial platelet disorder with associated myeloid malignancy	Pathogenic(Last reviewed: Jul 29, 2019)	reviewed by expert panel	VCV000376018	21	36231783	21	34859486	376018	362897	rs1057519748	NC_000021.9:34859485:G:A
NM_007194.4(CHEK2):c.715G>T (p.Glu239Ter)	CHEK2	E239*, E18*, E172*, E282*	not provided|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Prostate cancer, somatic	Pathogenic(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000005599	22	29107974	22	28711986	5599	20638	rs121908702	NC_000022.11:28711985:C:A
NM_000268.4(NF2):c.169C>T (p.Arg57Ter)	NF2	R57*	Meningioma|not provided|Neurofibromatosis, type 2	Pathogenic(Last reviewed: Jul 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000003285	22	30032794	22	29636805	3285	18324	rs121434259	NC_000022.11:29636804:C:T
NM_001323289.2(CDKL5):c.1675C>T (p.Arg559Ter)	CDKL5	R559*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143781	X	18622719	X	18604599	143781	153513	rs267608395	NC_000023.11:18604598:C:T
NM_002049.3(GATA1):c.89C>G (p.Ser30Ter)	GATA1	S30*	Acute megakaryoblastic leukemia in down syndrome|Thrombocytopenia, X-linked, with or without dyserythropoietic anemia|Diamond-Blackfan anemia	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000465134	X	48649605	X	48791198	465134	471606	rs1557020021	NC_000023.11:48791197:C:G
NC_012920.1:m.3243A>G	MT-TL1		Short stature|Glucose intolerance|Sensorineural hearing loss|Stroke|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF syndrome|Mitochondrial diseases|not provided|Diabetes-deafness syndrome maternally transmitted|Juvenile myopathy, encephalopathy, lactic acidosis AND stroke|MERRF/MELAS overlap syndrome|Leigh syndrome|Muscle stiffness, painful|Age-related macular degeneration 2|Cyclical vomiting syndrome|3-Methylglutaconic aciduria type 1|Mitochondrial complex IV deficiency	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000009589	MT	3243	MT	3243	9589	24628	rs199474657	NC_012920.1:3242:A:G
